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Abstract
Vascular endothelial growth factor receptors (VEGFRs) are receptor tyrosine kinases (RTKs) that regulate
proliferation, migration, angiogenesis and vascular permeability of endothelial cells. Vascular endothelial growth
factor receptor 1 (VEGFR1) and receptor 2 (VEGFR2) bind vascular endothelial growth factors (VEGFs),
inducing receptor dimerisation and activation, characterised by phosphorylation of tyrosine residues in their
cytoplasmic domain. Although recent experimental evidence suggests that RTK signalling occurs both on the
plasma membrane and intra-cellularly, and reveals the role of endocytosis in RTK signal transduction, we still
lack knowledge of VEGFR phosphorylation-site use and of the spatiotemporal regulation of VEGFR signalling. In
this paper, we introduce four stochastic mathematical models to study the binding kinetics of vascular endothelial
growth factor VEGF-A to VEGFR1 and VEGFR2, and RTK phosphorylation. The formation of phosphorylated
(homo- and hetero-) dimers on the cell surface is a two-step process: diffusive transport and binding. The first
two of our models (Model 1 and Model 2) only consider VEGFR2. This simplification allows us to introduce
new stochastic descriptors making use of a matrix-analytic approach. The two remaining models (Model 3.1
and Model 3.2) describe the competition of VEGFR1 and VEGFR2 for ligand availability, and are analysed
making use of Gillespie (stochastic) simulations and the van Kampen approximation. Under the hypothesis that
bound phosphorylated receptor dimers are the signalling units, we study the time to reach a threshold number of
such complexes. Our results indicate that the presence of VEGFR1 does not only affect the timescale to reach
a given signalling threshold, but it also affects the maximum attainable threshold. This result is consistent with
the conjectured role of VEGFR1 as a decoy receptor, that prevents VEGF-A binding to VEGFR2, and thus,
VEGFR2 attaining suitable phosphorylation levels. We identify an optimum range of ligand concentration for
sustained dimer phosphorylation. Finally, sensitivity analysis identifies the rate of monomer formation as the
parameter that our descriptors depend most strongly on.
Keywords: VEGFR; stochastic model; phosphorylation; stochastic descriptor; signalling threshold.
1 Introduction
Vascular endothelial growth factors (VEGFs) are a family of bivalent ligands consisting of mammalian and virus-
encoded members. The first discovered member was VEGF-A [1]. The ligand occurs in different isoforms of varying
lengths. Mounting evidence suggests that the various isoforms are involved in diverse cellular responses [2]. VEGFs
specifically bind to three type-V receptor tyrosine kinases (RTKs), VEGFR1, VEGFR2 and VEGFR3, as well as
co-receptors, such as neuropilins. In physiological conditions, the vascular endothelium expresses VEGFR1 and
VEGFR2, whereas the lymphatic endothelium expresses VEGFR2 and VEGFR3 [3]. Each receptor has an extra-
cellular domain for binding ligand, a trans-membrane domain, and an intra-cellular or cytoplasmic domain [4]. Like
many other RTKs, VEGFRs normally require dimerisation to become activated: once VEGF binds to VEGFRs,
the intra-cellular domains become activated through auto-phosphorylation and start cascades of intra-cellular
enzymatic reactions [2].
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In order to model endothelial cell behaviour regulated by VEGFR/VEGF signalling, initial cell surface binding
events and subsequent intra-cellular trafficking processes must be first quantified. Once this foundation is estab-
lished, cellular behaviour can more easily be analysed based on the number, state, and location of all molecules
and complexes involved. The receptor population is involved in binding to other receptors or membrane associated
molecules, internalisation, recycling, degradation and synthesis, broadly termed “trafficking” events. Both VEGFR
monomers and VEGFR dimers undergo internalisation by the same mechanism. The molecules are internalised and
transferred to the early endosome, in a process called endocytosis. After entering the early endosome, monomeric
and dimeric VEGFRs follow different pathways. The latter are transported to the late endosome and then to the
lysosome for degradation, whereas the former are rapidly recycled to the membrane [5].
VEGF-induced signalling cascades can cause diverse cellular responses such as cell motility, division or death
(i.e., apoptosis). Thus, a quantitative study of binding and phosphorylation kinetics is crucial to the understanding
of processes like angiogenesis and vasculogenesis. In Ref. [1] a stochastic model is proposed which includes binding,
dimerisation, endocytosis and early signalling events (activation of enzymes carrying an SH2 domain). The authors
carry out an analysis of the master equation of the process, by a generalisation of the Wentzel-Kramers-Brillouin
method, to address the contribution of ligand-induced receptor dimerisation, activation of src-homology-2 domain-
carrying kinases and receptor internalisation in the behaviour of the VEGF/VEGFR system, where only one
receptor type is considered (VEGFR2).
In order to analyse in detail the dimerisation and phosphorylation kinetics on the cell membrane, it is usual to
consider mathematical models which neglect internalisation events, and strictly focus on the biochemical reactions
taking place on the cell surface. In Ref. [6] the authors introduce a comprehensive set of models with different
dimerisation pathways: the first allowing pre-dimerisation without ligand and the second considering only ligand-
induced receptor dimerisation. In this way, the authors can address the role of pre-formed dimers in the binding
process. It is also worth mentioning Ref. [2], where the authors reported that blood flow might activate VEGFRs
in a ligand-independent manner (promoting the activation of mechano-sensory complexes). The consideration of
more than one receptor type in Ref. [6] is also essential, given that the authors note that prostacyclin synthesis has
been reported to be under the control of VEGFR heterodimers, which suggests that the signalling of heterodimers
is unique and significant for cellular responses. In most papers, VEGFR1 is often neglected, even when it might
be essential for the recruitment of haematopoietic precursors and migration of monocytes and macrophages [2].
Furthermore, in many biological responses to VEGF, the contribution of both VEGFR1 and VEGFR2 might be
required for a balanced signalling [2]. VEGFR signal transduction models have to provide a context for potential
communication between different VEGF receptors at the plasma membrane (through heterodimerisation). There-
fore, the dynamics of competition for ligand availability between VEGFR1 and VEGFR2 needs still to be analysed
in greater depth.
There is a wealth of previous studies that have developed mathematical models of RTKs and their role in
cellular responses. For example, in Ref. [7] the authors consider a different receptor tyrosine kinase, the epithelial
growth factor receptor (EGFR) to study the role of epithelial growth factor (EGF) on B82 fibroblasts. They argue
that the receptor signal is generated at a rate proportional to the number of activated receptors present, so that
the amount of phosphorylated dimers is directly related to the initiation of signalling cascades. In Ref. [8], the
authors consider a mathematical model of pre-formed RTK dimers, with instantaneous phosphorylation of dimers
upon ligand binding. However, phosphorylation is in fact a multi-step process, in which the different tyrosine
domains of each receptor transfer phosphate (from ATP) onto specific tyrosine residues of the partner receptor,
i.e., trans-autophosphorylation [2]. In Ref. [9], stochastic models of receptor oligomerisation by a bivalent ligand
are introduced to study the role of ligand-induced receptor cross-linking in cell activation. A particular feature
of this study is that a small number of receptors is considered, making a stochastic approach more suitable than
a deterministic one (see Ref. [10] for a comparison between deterministic and stochastic approaches in VEGFR
models). In order to relate receptor-ligand dynamics on the cellular membrane to cell activation, the authors
introduce a threshold number, θ, of bound oligomers that need to be formed before a cellular response can take
place. Once the stochastic process reaches this threshold, they study (by means of Gillespie simulations) the
probability of staying above this threshold for a given time, T = 10 k−1off , which is identified with the time required
for the activation of kinases and for the signalling pathway to be initiated [9].
In this paper, we aim to study the dynamics of VEGFR1, VEGFR2 and VEGF-A. We first focus on the
binding kinetics of VEGFR2/VEGF-A on the cell surface, and introduce a mathematical model (Model 1), in which
monomeric receptors, VEGFR2, can bind a bivalent ligand, VEGF-A, and receptor dimerisation is ligand induced.
This model is similar to Model 1 of Ref. [9]. However, in order to circumvent the need to introduce a fixed time
to stay above the threshold to lead to a cellular response, we consider phosphorylation an intrinsic characteristic
of the cross-linked VEGFR2 dimers. In Model 1, dimers are considered to be instantaneously phosphorylated,
so that the time to initiate the signalling cascade is identified with the time to reach a given threshold number
of phosphorylated dimers. In Model 2, phosphorylation of dimers is considered as a new reaction in the process,
and we equally consider the possibility of dimer de-phosphorylation. We then compute the time to reach a given
threshold number of phosphorylated dimers in Model 2. Finally, and in order to study the role of VEGFR1 in the
dynamics of VEGFR2 and VEGF-A, we introduce two stochastic models (Model 3.1 and Model 3.2), which are
extensions of Model 1 and Model 2, respectively, in the presence of VEGFR1.
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As stated in Ref. [9], the analytical treatment of multi-variate stochastic processes is usually extremely difficult,
and numerical approaches, such as Gillespie simulations, are used instead. However, it is still possible to carry
out an analytical study of these processes without solving the master equation. Here we make use of a matrix-
analytical technique in order to consider a number of stochastic descriptors, conveniently defined in the spirit of
Ref. [9]. This matrix-analytic approach, which has its origins in the seminal work by M. Neuts [11], allows us to
study the stochastic descriptors of interest for moderate concentrations of ligands and receptors, as discussed in
Section 2. Matrix-analytic techniques have historically been developed in the context of Queueing Theory [12].
However, more recently, they have been applied in Mathematical Biology [13, 14] (competition model between two
species of individuals).
The paper is organised as follows. In Section 2, four different stochastic models are introduced to describe
the binding dynamics of receptor monomers and dimers on the surface of endothelial cells. The models include
phosphorylation or competition for ligand availability. Matrix-analytic techniques are applied, when possible, in
order to study different stochastic descriptors of interest in the VEGF-A/VEGFR system. One special property
of this method is that a sensitivity analysis for the effect of binding, dissociation and phosphorylation rates on the
stochastic descriptors can be carried out. In Section 3, parameter estimation is carried out following arguments
first described in Ref. [4]. Finally, numerical results are described in Section 4, followed by a discussion in Section 5.
Standard notation used throughout the paper is introduced in Appendix A, and different matrices and algorithms
defined in the paper are specified in Appendices B and C. The application of the Van Kampen approximation [15],
when dealing with the master equation (to study the transient behaviour of the Markov chains under consideration),
is discussed in Section 5, and this method is shortly reviewed in Appendix D.
2 Stochastic models
In this Section, we introduce three different stochastic models for the binding kinetics of two different VEGFRs,
VEGFR1 and VEGFR2, to the bivalent ligand VEGF-A, taking place on the membrane of a vascular endothelial
cell. We consider a bivalent ligand that can bind to plasma membrane receptors, creating receptor-with-ligand
monomers. The free pole of the ligand in a monomer can then bind to free receptors during the diffusion of these
receptors on the cell surface, creating dimers consisting of two receptors bound to the ligand. Dimerisation of
receptors is only induced by ligands in our model and two free receptors are not able to create a pre-dimer without
ligand (ligand-induced dimerisation or LID). This is consistent with Ref. [16] and is the main assumption in Ref. [6,
LID Model]. There is also experimental support for this hypothesis: free VEGFR2 is observed (electron microscopy)
in monomeric form on the cell surface [17]. We note that, for low to moderately high ligand concentrations, as
discussed in Section 4, no significant differences are expected in our results by including pre-dimerisation [6]. Yet,
this would significantly increase our model complexity. The relevance in the system dynamics of pre-dimers is only
expected under highly saturated situations; see, for example, Ref. [6, Figures 2 and 3] for details, and Figure 12,
of this paper for further details related to this matter.
In SubSection 2.1 and SubSection 2.2, we consider the processes where only VEGFR2 is expressed on the
cell surface. In particular, in SubSection 2.1, we propose a stochastic model in which dimers are assumed to
instantaneously phosphorylate, so that these dimers amount to the signalling complexes on the plasma membrane,
and the number of these complexes becomes a direct measure of signalling. In SubSection 2.2, an extended model
is considered, where phosphorylation (and de-phosphorylation) are included as new reactions in the process: non-
phosphorylated dimers may eventually become phosphorylated, and these phosphorylated dimers are the complexes
initiating the signalling cascade. In any model considered in this paper, phosphorylation of a cross-linked dimer
is considered to be the synchronised activation of all the tyrosine kinase residues in the intra-cellular tail of the
receptors. However, phosphorylation is a multi-step process, in which the different tyrosine domains of each
receptor transfer phosphate (from ATP) onto specific tyrosine residues of the partner receptor [2]. Our approach
should be then viewed as an intermediate alternative between modelling phosphorylation in an instantaneous
way (Model 1 in Subsection 2.1, as well as most of the published models, such as Refs. [9, 1]), and considering
dimer phosphorylation as a multi-step process, where each tyrosine residue becomes phosphorylated upon ligand
stimulation, which is out of the scope of this paper. Thus, the mathematical models developed here will allow us
to consider the phosphorylation of bound and cross-linked VEGFR dimers as a separate reaction and how it affects
the dynamics of the VEGF-VEGFR association and dissociation. This reaction was discussed in Ref. [6] but not
included in the mathematical model. In SubSection 2.3, two different variants of a third model are considered to
analyse the competition dynamics between VEGFR1 and VEGFR2, when both are expressed on the cell surface.
Finally, a sensitivity analysis is developed in SubSection 2.4 in order to understand how the binding, dissociation
and phosphorylation rates affect the dynamics of the ligand/receptor system.
The study of the number of monomer, non-phosphorylated and phosphorylated dimer molecules on the cell
surface over time can be viewed as the analysis of the transient behaviour of a specific Markov chain, a problem
which, in general, is not solvable in closed form [18]. Therefore, one typically carries out Gillespie simulations [19], or
applies moment-closure techniques [20, 21] to deal with the master equation of the Markov process under study. In
this paper, we follow both approaches to study the multi-variate competition models introduced in SubSection 2.3.
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However, for models in SubSection 2.1 and SubSection 2.2, it is possible to apply alternative procedures in order to
analyse, in an exact way, different characteristics of the processes under consideration. In particular, the matrix-
analytic approach is described in SubSection 2.1 and SubSection 2.2, by studying the Laplace-Stieltjes transforms
of particular random variables of interest, and making use of first-step arguments and auxiliary absorbing Markov
chains conveniently defined. Moreover, a novel local sensitivity analysis for the Markov chains under study is
adapted and applied in SubSection 2.4, by generalising arguments from Ref. [22]. This analysis allows us to
identify how the stochastic descriptors (considered in SubSection 2.1 and SubSection 2.2), are affected by the
binding, dissociation and phosphorylation rates.
2.1 Model 1: instantaneous phosphorylation
In this Section, we consider a model of the bivalent ligand VEGF-A that can bind VEGFR2 to form M2 complexes.
Free receptors can diffuse on the cell surface, so that eventually they react with bound monomers M2, to form ligand-
bound and cross-linked receptor dimers, termed P2 complexes. Once a P2 complex is formed, it is instantaneously
phosphorylated, so that the P2 complexes on the plasma membrane initiate signalling, in the spirit of Refs. [9, 7].
Finally, both bound monomers and dimers can dissociate. We assume that de-phosphorylation of P2 complexes
is fast (see Table 2), and that it takes place when cross-linked receptor dimers dissociate. In this scenario four
possible reactions can occur with different binding and dissociation rates as shown in Figure 1.
Figure 1: Reactions in Model 1. a) Formation and dissociation of bound monomers (M2). b) Formation and dis-
sociation of bound dimers (P2), which instantaneously phosphorylate (represented by red phosphorylated residues
in the intra-cellular tail of the receptors).
In what follows, we consider an environment with constant numbers, nR2 and nL, of receptors and ligands
spatially well-mixed on the cell surface or in the extra-cellular space, respectively. We are interested in the number
of M2 and P2 complexes on the cell surface as a function of time, which we model using a stochastic approach:
as a continuous time Markov chain (CTMC) X = {X(t) = (M2(t), P2(t)) : t ≥ 0}, where M2(t) and P2(t)
represent the number of M2 and P2 complexes, respectively, at time t. We note that, if we define the random
variables R2(t) and L(t) as the numbers of free receptors and ligands, respectively, at time t ≥ 0, it is clear that
R2(t) = nR2 −M2(t) − 2P2(t) and L(t) = nL −M2(t) − P2(t) for all t ≥ 0. Then, R2(t) and L(t) are implicitly
analysed in X and do not need to be explicitly considered in the CTMC. Moreover, it is clear that M2(t), P2(t) ≥ 0
and, from the previous comments
L(t) ≥ 0 ⇒ M2(t) + P2(t) ≤ nL,
R2(t) ≥ 0 ⇒ M2(t) + 2P2(t) ≤ nR2 ,
for all t ≥ 0, which specifies the space of states S of X . Specifically, we note that given (M2(t), P2(t)) = (n1, n2)
at some time instant t ≥ 0, then
• if 2nL ≤ nR2 : n1 + n2 ≤ nL ⇒ n1 + 2n2 ≤ nR2 , and
• if nR2 ≤ nL: n1 + 2n2 ≤ nR2 ⇒ n1 + n2 ≤ nL,
so that three different specifications of the space of states S are obtained, depending on the particular values of
nR2 and nL. In particular:
• if 2nL ≤ nR2 , then S = {(n1, n2) ∈ (N ∪ {0})2 : n1 + n2 ≤ nL},
• if nR2 < 2nL < 2nR2 , then S = {(n1, n2) ∈ (N ∪ {0})2 : n1 + n2 ≤ nL, n1 + 2n2 ≤ nR2}, and
• if nR2 ≤ nL, then S = {(n1, n2) ∈ (N ∪ {0})2 : n1 + 2n2 ≤ nR2}.
Although we can deal with each of these cases in a similar manner, we only consider the case 2nL ≤ nR2 , since
this is the case under physiological conditions of VEGFR2, see e.g., Ref. [23]. In this case, X is defined over
S = {(n1, n2) ∈ (N ∪ {0})2 : n1 + n2 ≤ nL}. From Figure 1, it is clear that transitions from states in the interior
of S, that is, from states (n1, n2) ∈ N2 with n1 + n2 < nL, can be to four adjacent states as shown in Figure 2.
Transitions for states within the boundary of S are obtained in a similar way by discarding those transitions that
leave S.
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Figure 2: Transition diagram for model 1.
Transitions between states in our CTMC are governed by the infinitesimal transition rates q(n1,n2),(n′1,n′2), with
(n1, n2), (n
′
1, n
′
2) ∈ S. These infinitesimal transition rates are obtained by mass action kinetics, and by the fact
that if the process is in state (n1, n2) at a given time, there are (nL−n1−n2) free ligands and (nR2−n1−2n2) free
receptors available. Formation of M2 complexes directly depends on the number of free receptors and ligands, while
their dissociation only depends on the number of M2 complexes. Similar comments can be made for P2 complexes.
Finally, we note that formation of M2 complexes and dissociation of P2 complexes can take place with one of the
two available poles of the ligand involved in the reaction. Then, the specific values of the non-null infinitesimal
transition rates are given by
q(n1,n2),(n′1,n′2) =

2α+(nR2 − n1 − 2n2)(nL − n1 − n2), if (n′1, n′2) = (n1 + 1, n2),
α−n1, if (n′1, n
′
2) = (n1 − 1, n2),
β+n1(nR2 − n1 − 2n2), if (n′1, n′2) = (n1 − 1, n2 + 1),
2β−n2, if (n′1, n
′
2) = (n1 + 1, n2 − 1),
(1)
where α+, α−, β+ and β− are positive constants representing binding and dissociation rates for M2 and P2 com-
plexes, respectively.
Our objectives in this Section amount to study two descriptors of interest:
1. Starting from any state (n1, n2) ∈ S, the time to reach a number N2 > n2 of P2 complexes.
2. Starting from any state (n1, n2) ∈ S, the stationary distribution of the process.
Descriptor 2 allows us to obtain the theoretical state of the system at steady state, thus enabling us to analyse
the long-term dynamics, for example, for different initial numbers of ligand and receptor. Descriptor 1 is the most
relevant and useful, since it is the time to reach some pre-defined threshold number of signalling complexes, or
equivalently a pre-defined threshold for cell activation (see Refs. [9, 7]). One of our aims is to analyse how this time
depends on the binding and dissociation rates, as well as on the numbers of ligand and receptor on the cell surface.
Numerical results obtained in Section 4 show, by means of two competition models introduced in SubSection 2.3,
how the presence of a VEGFR2 competitor, VEGFR1, induces a delay in the time to reach a given threshold of
P2 complexes.
The analysis carried out in this Section is based in the use of levels for the organisation of state space, Laplace-
Stieltjes transforms, first-step arguments and auxiliary absorbing Markov chains. Although the theoretical results
and algorithms presented in this Section are valid regardless of the exact values of nL and nR2 (with 2nL ≤ nR2),
the dimensionality of the state space, S, can become computationally intractable, even for moderate values of the
total number of ligands nL, since
#S = (nL + 1)(nL + 2)
2
.
Thus, in order to minimise the computational effort in our procedures, a strong focus on algorithmic issues is
necessary throughout the paper. We first organise the space of states S by levels (groups of states) as
S =
nL⋃
k=0
L(k),
where L(k) = {(n1, n2) : n2 = k}, 0 ≤ k ≤ nL, so that J(k) = #L(k) = nL−k+ 1. That is, a level L(k) comprises
all the possible states (n1, n2) of the process with a total number of P2 complexes equal to k. Moreover, we order
these levels as
L(0) ≺ L(1) ≺ · · · ≺ L(nL),
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and states inside a level, L(k) = {(0, k), (1, k), . . . , (nL − k, k)}, 0 ≤ k ≤ nL, are ordered as
(0, k) ≺ (1, k) ≺ · · · ≺ (nL − k, k).
Given the transitions of Figure 2, it is clear that from a state (n1, n2) at level L(n2), the process can only move
to states in the same level, L(n2), and to states at adjacent levels, L(n2− 1) and L(n2 + 1). That is, if the state of
the system is (n1, n2) (and then, the process is in level L(n2)), the only possible transitions are to (n1 − 1, n2) (if
a monomer dissociates, in which case the process remains in level L(n2)), to (n1 + 1, n2) (if a monomer is formed,
leaving the process in level L(n2)), to (n1 + 1, n2 − 1) (if a dimer dissociates, and the process then decreases to
level L(n2 − 1)), or to (n1 − 1, n2 + 1) (if a dimer is created, increasing the level of the process to L(n2 + 1)).
The organisation of S, previously proposed, becomes crucial in order to obtain a convenient structure for the
infinitesimal generator Q of X , the matrix containing the transition rates in the Markov chain. Specifically, the
above yields an infinitesimal generator which has the following tridiagonal-by-block structure
Q =

A0,0 A0,1 0J(0)×J(2) . . . 0J(0)×J(nL−1) 0J(0)×J(nL)
A1,0 A1,1 A1,2 . . . 0J(1)×J(nL−1) 0J(1)×J(nL)
0J(2)×J(0) A2,1 A2,2 . . . 0J(2)×J(nL−1) 0J(2)×J(nL)
...
...
...
. . .
...
...
0J(nL−1)×J(0) 0J(nL−1)×J(1) 0J(nL−1)×J(2) . . . AnL−1,nL−1 AnL−1,nL
0J(nL)×J(0) 0J(nL)×J(1) 0J(nL)×J(2) . . . AnL,nL−1 AnL,nL

,
(2)
where sub-matrices Ak,k′ contain the infinitesimal transition rates of the transitions from states at level L(k) to
states at level L(k′), with k′ ∈ {k − 1, k, k + 1}. Expressions for sub-matrices Ak,k′ are directly derived from (1),
and are specified in Appendix B.1.
Firstly, we consider the time to obtain a number N2 > 0 of P2 complexes. In particular, given an initial state
of the process (n1, n2), and a certain threshold N2 > 0, we consider the random variable
T(n1,n2)(N2) = “Time to reach a number of P2 complexes equal to N2 in X ,
if the process starts at (n1, n2) ∈ S”.
We observe that this time is 0 for N2 ≤ n2. In order to study this descriptor for N2 > n2, we make use of an
auxiliary CTMC, X (N2), which depends on the threshold value N2. We define X (N2) over S(N2) with
S(N2) = C(N2) ∪ {N¯2},
where we denote C(N2) = ∪N2−1k=0 L(k), and where N¯2 is a macro-state obtained by lumping together all states
in the set ∪nLk=N2L(k). Regarding the transition rates of this auxiliary CTMC, we retain those transitions of X
between states in C(N2), and we consider N¯2 as an absorbing macro-state, so that once X (N2) enters N¯2, it does
not leave this state. Transitions from states in level L(N2−1) to states in L(N2) of the original process X , become
transitions from states in level L(N2−1) to the macro-state N¯2 in X (N2), where their infinitesimal transition rates
are directly obtained from the original ones as follows:
q(n1,n2),N¯2 =
∑
(n′1,n
′
2)∈L(N2)
q(n1,n2),(n′1,n′2), ∀(n1, n2) ∈ L(N2 − 1).
The process X (N2) can be seen as the process X until N2 of P2 complexes are formed. Then, X (N2) ends since
N¯2 is an absorbing state for this auxiliary process. With X (N2) so defined, it is clear that the time taken to
obtain a number N2 of P2 complexes in the original process X is equal to the time until absorption at N¯2 in the
absorbing process X (N2), which is known to follow a continuous phase-type (PH) distribution, see e.g., Refs. [18, 12].
Analysing the exact distribution of a continuous PH distribution, in general, is a (well known) difficult problem. In
our case, it would imply obtaining the exponential matrix exp(T(N2)) =
∑+∞
n=0
T(N2)
n
n! , where T(N2) is a specific
sub-matrix of the infinitesimal generator of X (N2). Here, we instead make use of the Laplace-Stieltjes transform
of T(n1,n2)(N2), which completely determines its distribution, and which allows us to obtain any l-th order moment
E[T(n1,n2)(N2)
l]. Moreover, we can efficiently calculate the l-th order moment by using the (l−1)-th order moment,
proceeding recursively, with the computational effort devoted to obtaining inverses of square blocks Ak,k, which
have dimension J(k) = nL − k + 1. Again, the proposed organisation of states is crucial for the construction of an
efficient algorithm. If we define the Laplace-Stieltjes transform of T(n1,n2)(N2) as
φN2(n1,n2)(z) = E
[
e−zT(n1,n2)(N2)
]
, <(z) ≥ 0,
then, the different l-th order moments of T(n1,n2)(N2) can be obtained as
E
[
T(n1,n2)(N2)
l
]
= (−1)l d
l
dzl
φN2(n1,n2)(z)
∣∣∣∣
z=0
, ∀l ≥ 1.
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We can apply a first-step argument in order to obtain a system of linear equations for the Laplace-Stieltjes trans-
forms φN2(n1,n2)(z), given a state (n1, n2) ∈ S(N2). We can write down the equation
φN2(n1,n2)(z) = (1− δn1+n2,nL)
2α+(nR2 − n1 − 2n2)(nL − n1 − n2)
z +A(n1,n2)
φN2(n1+1,n2)(z) + (1− δn1,0)
× α−n1
z +A(n1,n2)
φN2(n1−1,n2)(z) + (1− δn1,0)
β+n1(nR2 − n1 − 2n2)
z +A(n1,n2)
(
δn2,N2−1 (3)
+(1− δn2,N2−1)φN2(n1−1,n2+1)(z)
)
+ (1− δn2,0)
2β−n2
z +A(n1,n2)
φN2(n1+1,n2−1)(z),
where from now on A(n1,n2) = 2α+(nR2 − n1 − 2n2)(nL − n1 − n2) + α−n1 + β+n1(nR2 − n1 − 2n2) + 2β−n2.
Eq. (3) relates the Laplace-Stieltjes transforms corresponding to all the states of S(N2), so that a system of linear
equations is obtained. If we organise the Laplace-Stieltjes transforms in vectors by levels as follows
gN2(z) = (gN20 (z)
T ,gN21 (z)
T ,gN22 (z)
T , . . . ,gN2N2−1(z)
T )T ,
with gN2k (z) = (φ
N2
(0,k)(z), φ
N2
(1,k)(z), φ
N2
(2,k)(z), . . . , φ
N2
(nL−k,k)(z))
T , for 0 ≤ k ≤ N2 − 1, then the system given in (3)
can be expressed in matrix form as
gN2(z) = AN2(z) gN2(z) + aN2(z), (4)
with the matrix AN2(z) given by
A0,0(z) A0,1(z) 0J(0)×J(2) . . . 0J(0)×J(N2−2) 0J(0)×J(N2−1)
A1,0(z) A1,1(z) A1,2(z) . . . 0J(1)×J(N2−2) 0J(1)×J(N2−1)
0J(2)×J(0) A2,1(z) A2,2(z) . . . 0J(2)×J(N2−2) 0J(2)×J(N2−1)
...
...
...
. . .
...
...
0J(N2−2)×J(0) 0J(N2−2)×J(1) 0J(N2−2)×J(2) . . . AN2−2,N2−2(z) AN2−2,N2−1(z)
0J(N2−1)×J(0) 0J(N2−1)×J(1) 0J(N2−1)×J(2) . . . AN2−1,N2−2(z) AN2−1,N2−1(z)

,
and the vector
aN2(z) =

0J(0)
0J(1)
...
0J(N2−2)
aN2−1(z)
 .
Sub-matrices Ak,k′(z) and the sub-vector aN2−1(z) are given in Appendix B.2. Exploiting the special block
structure of AN2(z), allows for an efficient solution of the system in (4), in a recursive manner through a specialised
block-Gaussian elimination process. This gives us Algorithm 1 (Part 1) listed in Appendix C. The calculation of
the Laplace-Stieltjes transforms in Algorithm 1 (Part 1) has its own merit, since it determines the distribution of
the random variable under consideration. Moreover, the calculation of the distribution function of T(n1,n2)(N2) by
numerical inversion of the transform is possible, although computationally expensive, and is not developed here
(see e.g., Ref. [24]).
Once the Laplace-Stieltjes transforms are in hand, we can obtain the different l-th order moments by successive
differentiation of the system in (4). In particular, we can write
mN2,(l) =
l∑
p=0
(−1)p
(
l
p
)
dp
dzp
AN2(z)
∣∣∣∣
z=0
mN2,(l−p) + (−1)l d
l
dzl
aN2(z)
∣∣∣∣
z=0
, (5)
where mN2,(l) is the column vector containing the desired moments E[T(n1,n2)(N2)
l], for (n1, n2) ∈ C(N2). We
organise these moments in sub-vectors by levels as
mN2,(l) = (m
N2,(l)T
0 ,m
N2,(l)T
1 ,m
N2,(l)T
2 , . . . ,m
N2,(l)T
N2−1 )
T ,
with m
N2,(l)
k = (E[T(0,k)(N2)
l], E[T(1,k)(N2)
l], E[T(2,k)(N2)
l], . . . , E[T(nL−k,k)(N2)
l])T , for 0 ≤ k ≤ N2 − 1. Note
that the notation mN2,(0) = gN2(0) = e#C(N2) is implicit in (5). That is, the moment of order l = 0 is the Laplace-
Stieltjes transform for z = 0. Finally, the system in (5) is rewritten following the calculus notation presented in
Appendix A, as follows:
mN2,(l) = AN2(0)mN2,(l) +
l∑
p=1
(
l
p
)
(−1)pAN2,(p)(0)mN2,(l−p) + (−1)laN2,(l)(0). (6)
7
It is clear that the direct calculation of the inverse (I#C(N2) − AN2(0))−1 involved in the solution of (6) can be
avoided by working by levels and solving (6) in a similar way to Algorithm 1 (Part 1). By starting with the known
moment of order p = 0, we proceed recursively by calculating mN2,(p) from mN2,(p−1), until the desired order
p = l is reached. This gives us Algorithm 1 (Part 2) listed in Appendix C. Expressions for the derivative matrices
AN2,(p)(0) and aN2,(p)(0) are given in Appendix B.3.
Finally, the long term behaviour of the process is given by the stationary distribution of the CTMC; that is,
the probabilities
pi(n1,n2) = limt→+∞P((M2(t), P2(t)) = (n1, n2)), ∀(n1, n2) ∈ S,
which do not depend on the initial state. We can store this distribution in a row vector pi = (pi0,pi2, . . . ,pinL),
where the row sub-vector pik contains the ordered probabilities pi(n1,n2) for states at level L(k). Solving the system
piQ = 0T#S and pie#S = 1,
and adapting the arguments in Ref. [12, Chapter 10], we obtain Algorithm 2 listed in Appendix C. With pi in hand,
the long term mean number of M2 and P2 complexes can be obtained as
m1 = “Mean number of M2 complexes in steady state” =
nL∑
k=0
k
 nL∑
j=0
(pij)k
 ,
m2 = “Mean number of P2 complexes in steady state” =
nL∑
k=0
k
(
pikeJ(k)
)
.
2.2 Model 2: delayed phosphorylation
In the previous Section, the P2 complexes were instantaneously phosphorylated. Here we relax this requirement
and include phosphorylation as an additional reaction (see Figure 3). In what follows, we adapt the arguments of
the previous Section to this model. This allows us not only to evaluate the relevance of considering phosphorylation
as an independent reaction (with numerical results presented in Section 4), but also serves as an example of how
to include new reactions in this type of models, while adapting the matrix-analytic arguments.
Figure 3: Reactions in Model 2. a) Formation and dissociation of bound monomers (M2). b) Formation and
dissociation of non-phosphorylated dimers (D2). c) Formation and de-phosphorylation of phosphorylated dimers
(P2).
In brief, we consider the CTMC Xˆ = {Xˆ(t) = (Mˆ2(t), Dˆ2(t), Pˆ2(t)) : t ≥ 0}, where
Mˆ2(t) = “Number of M2 complexes at time t”,
Dˆ2(t) = “Number of D2 complexes at time t”,
Pˆ2(t) = “Number of P2 complexes at time t”,
for all t ≥ 0, where D2 complexes refer to non-phosphorylated dimers and P2 to phosphorylated ones. From the
reactions in Figure 3, it is clear that for all t ≥ 0
Mˆ2(t) + Dˆ2(t) + Pˆ2(t) ≤ nL,
Mˆ2(t) + 2Dˆ2(t) + 2Pˆ2(t) ≤ nR2 ,
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and, by assuming as previously that 2nL ≤ nR2 , it is straightforward to show that
Mˆ2(t) + Dˆ2(t) + Pˆ2(t) ≤ nL, ∀t ≥ 0 ⇒ Mˆ2(t) + 2Dˆ2(t) + 2Pˆ2(t) ≤ nR2 , ∀t ≥ 0,
so that Xˆ is defined over Sˆ = {(n1, n2, n3) ∈ (N ∪ {0})3 : n1 + n2 + n3 ≤ nL}. We are thus, interested in the
following descriptors, analogous to those of the previous Section:
1. Starting from any state (n1, n2, n3) ∈ Sˆ, the time to reach a number N3 > n3 of P2 complexes.
2. Starting from any state (n1, n2, n3) ∈ Sˆ, the stationary distribution of the system.
To study these descriptors, we again use level structures for the state space, and split Sˆ in levels as follows:
Sˆ =
nL⋃
k=0
Lˆ(k),
where Lˆ(k) = {(n1, n2, n3) ∈ Sˆ : n3 = k}, for 0 ≤ k ≤ nL, so that
Jˆ(k) = #Lˆ(k) =
(nL − k + 1)(nL − k + 2)
2
.
The three-dimensionality of our process implies that each level Lˆ(k) may be split into different sub-levels, as follows:
Lˆ(k) =
nL−k⋃
r=0
l(k; r),
with l(k; r) = {(n1, n2, n3) ∈ Sˆ : n2 = r, n3 = k}, for 0 ≤ r ≤ nL − k, 0 ≤ k ≤ nL, and J(k; r) = #l(k; r) =
nL − r − k + 1. That is,
l(k; r) = {(0, r, k), (1, r, k), . . . , (nL − r − k, r, k)}, 0 ≤ r ≤ nL − k, 0 ≤ k ≤ nL,
and states in l(k; r) are ordered as indicated above. From Figure 3 the transition diagram can be obtained (Figure 4),
where non-null infinitesimal transition rates are obtained in a manner analogously to (1).
Figure 4: Transition diagram for model 2.
The given order of states and the organisation by levels and sub-levels, thus, yield an infinitesimal generator
similar to (2), where quantities J(k) and matrices Ak,k′ are replaced by Jˆ(k) and Aˆk,k′ , respectively. A matrix
Aˆk,k′ contains the ordered infinitesimal transition rates corresponding to transitions from states at level Lˆ(k) to
states at level Lˆ(k′). Each matrix Aˆk,k′ is formed by sub-blocks B
k,k′
r,r′ which contain the infinitesimal transition
rates corresponding to transitions from states at sub-level l(k; r) ⊂ Lˆ(k) to states at sub-level l(k′; r′) ⊂ Lˆ(k′). We
observe that the dimension of the matrix Aˆk,k′ is Jˆ(k) × Jˆ(k′) = (nL−k+1)(nL−k+2)2 × (nL−k
′+1)(nL−k′+2)
2 , while
the dimension of the sub-block Bk,k
′
r,r′ inside Aˆk,k′ is J(k; r) × J(k′; r′) = (nL − r − k + 1) × (nL − r′ − k′ + 1).
Expressions for these matrices are given in Appendix B.4.
For an initial state (n1, n2, n3) ∈ Sˆ and a number N3 > 0, we are now interested in the random variable
T(n1,n2,n3)(N3) = “Time to reach a number N3 of P2 complexes if the process
starts at (n1, n2, n3)”.
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We omit N3 in the notation for convenience, and denote the random variable under study T(n1,n2,n3). Again, this
time is 0 for N3 ≤ n3. For N3 > n3, we follow an argument similar to that of SubSection 2.1, so that the analysis
of an auxiliary absorbing CTMC requires the study of T(n1,n2,n3) as an absorption time in the auxiliary process.
In order to obtain the different l-th order moments in an efficient way, we define the Laplace-Stieltjes transform
of T(n1,n2,n3) as
ξ(n1,n2,n3)(z) = E
[
e−zT(n1,n2,n3)
]
, <(z) ≥ 0,
and the different l-th order moments of T(n1,n2,n3) can be obtained as
E
[
T l(n1,n2,n3)
]
= (−1)l d
l
dzl
ξ(n1,n2,n3)(z)
∣∣∣∣
z=0
, ∀l ≥ 1.
By a first-step argument (omitted here since it is analogous to (3)), we obtain the system
gˆ(z) = Aˆ(z) gˆ(z) + aˆ(z), (7)
where the Laplace-Stieltjes transforms are stored in vectors gˆ(z), following the order given by the levels and sub-
levels, and where the expressions for matrices Aˆ(z) and aˆ(z) are omitted for brevity. By successive differentiation
of the system in (7), we obtain the different l-th order moments E[T l(n1,n2,n3)] through an adapted version of
Algorithm 1, with N2 replaced by N3, and with the l-th order moments stored in the vectors mˆ
(l). We note that
in the adapted version of Algorithm 1 to solve (7), which is omitted, we need to deal with inverses of matrices
with dimension Jˆ(k) = #Lˆ(k). The complexity of transitions between states does not seem to allow us to gain
further efficiency in our algorithms by working with inverses of matrices with the dimensions of the given sub-levels.
However, in the special case γ− = 0, that is, when de-phosphorylation is neglected, it is possible to improve the
procedures so that the highest computational effort is placed on inverting matrices with the dimensions of sub-levels
instead of levels, which would yield an Algorithm 3, that is not described here.
Finally, we focus on the stationary distribution of the process, that is, the probabilities
pˆi(n1,n2,n3) = limt→+∞P((Mˆ2(t), Dˆ2(t), Pˆ2(t)) = (n1, n2, n3)), ∀(n1, n2, n3) ∈ Sˆ,
which do not depend on the initial state. Similar arguments to those considered in SubSection 2.1 allow us to
obtain the stationary distribution in a row vector pˆi = (pˆi0, pˆi2, . . . , pˆinL), where pˆik =
(
pˆik0 , pˆi
k
2 , . . . , pˆi
k
nL−k
)
, and
where row sub-vectors pˆikr contain, in an ordered manner, steady state probabilities of states at sub-levels l(k; r).
An adapted version of Algorithm 2 can be obtained, where the matrices Aj,j′ , in (2), would be now replaced by
the matrices Aˆk,k′ previously defined. Once these vectors are in hand, it is clear that
mˆ1 = “Mean number of M2 complexes in steady state” =
nL∑
i=0
i
(
nL−i∑
k=0
nL−i−k∑
r=0
(pˆikr )i
)
,
mˆ2 = “Mean number of D2 complexes in steady state” =
nL∑
r=0
r
(
nL−r∑
k=0
nL−r−k∑
i=0
(pˆikr )i
)
,
mˆ3 = “Mean number of P2 complexes in steady state” =
nL∑
k=0
k
(
nL−k∑
r=0
nL−r−k∑
i=0
(pˆikr )i
)
.
2.3 Model 3: competition between VEGFR1 and VEGFR2
In previous Sections, we have analysed the interaction between the bivalent ligand VEGF-A and the VEGFR2 on
the cell surface. However, both VEGFR1 and VEGFR2 are expressed on endothelial cells and can bind VEGF-
A [25]. VEGFR1 has a greater binding affinity to VEGF-A than VEGFR2, but as reported in Ref. [26], it may not
be a “receptor transmitting a mitogenic signal”, but a decoy receptor that prevents VEGF-A binding to VEGFR2.
On the other hand, VEGFR2 phosphorylation and signalling is required for the homeostasis of normal endothelial
cells [1]. We, therefore, do not consider VEGFR1 phosphorylation in the models that follow [27]. Then, VEGFR1
competes with VEGFR2 for ligand, and these receptors will induce different signalling pathways. Finally, VEGFR1
and VEGFR2 are found at different copy numbers in a variety of cell lines [28, 29]. Previous studies show that the
heterogeneity in these two receptor numbers contributes to a major complexity of the VEGF-A signal transduction
process, and should be studied further [6]. In this Section, we develop two competition models which include
VEGFR1, VEGFR2 and VEGF-A.
We first consider the case of instantaneous phosphorylation of bound receptor dimers (Model 3.1). In this
model two types of bound monomers can be formed, M1 and M2, as a result of the ligand binding to VEGFR1 and
VEGFR2, respectively. Then, ligand-induced receptor dimerisation leads to the formation of homodimers, D1 and
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Figure 5: Reactions of Model 3.1. a) Formation or dissociation of a bound monomer (M2). b) Formation and
dissociation of a bound monomer (M1). c) Formation or dissociation of bound homodimers (P2). d)−f) Analogous
reactions for homodimers D1 and heterodimers PM . VEGFR2 involved in a bound dimer becomes instantaneously
phosphorylated.
P2, or heterodimers PM . VEGFR2 homodimers are instantaneously phosphorylated. The complete set of reactions
of Model 3.1 is given in Figure 5.
We consider a CTMC X˜ = {X˜(t) : t ≥ 0} where the state vector X˜(t) ∈ S˜ ⊂ (N ∪ {0})5 is a collection of
discrete random variables representing the number of each type of complex at time t:
X˜(t) = (M˜1(t), M˜2(t), D˜1(t), P˜2(t), P˜M (t)),
and its joint probability distribution is given as
Pn(t) = P(X˜(t) = n),
where n = (n1, n2, n3, n4, n5) ∈ S˜. The space of states S˜ can be identified by the implicit restrictions imposed by
the reactions described in Figure 5, and the consideration of fixed numbers (nR1 , nR2 , nL) of receptors and ligands.
We may write the non-null infinitesimal transition rates, based on the reactions shown in Figure 5, as follow:
q(n,n′) =

2α1+(nL − n1 − n2 − n3 − n4 − n5)(nR1 − n1 − 2n3 − n5),
if n′ = (n1 + 1, n2, n3, n4, n5),
α1−n1, if n′ = (n1 − 1, n2, n3, n4, n5),
β11+n1(nR1 − n1 − 2n3 − n5), if n′ = (n1 − 1, n2, n3 + 1, n4, n5),
2β11−n3, if n′ = (n1 + 1, n2, n3 − 1, n4, n5),
β12+n1(nR2 − n2 − 2n4 − n5), if n′ = (n1 − 1, n2, n3, n4, n5 + 1),
β12−n5, if n′ = (n1 + 1, n2, n3, n4, n5 − 1),
2α2+(nL − n1 − n2 − n3 − n4 − n5)(nR2 − n2 − 2n4 − n5),
if n′ = (n1, n2 + 1, n3, n4, n5),
α2−n2, if n′ = (n1, n2 − 1, n3, n4, n5),
β22+n2(nR2 − n2 − 2n4 − n5), if n′ = (n1, n2 − 1, n3, n4 + 1, n5),
2β22−n4, if n′ = (n1, n2 + 1, n3, n4 − 1, n5),
β21+n2(nR1 − n1 − 2n3 − n5), if n′ = (n1, n2 − 1, n3, n4, n5 + 1),
β21−n5, if n′ = (n1, n2 + 1, n3, n4, n5 − 1),
(8)
and where q(n,n) = −
∑
n6=n′ q(n,n′). The dynamics of the model can be described by the master equation
dPn(t)
dt
=
∑
n′∈S ,n′ 6=n
q(n′,n) Pn′(t)−
∑
n′∈S ,n′ 6=n
q(n,n′) Pn(t) , ∀n ∈ S, (9)
with the initial condition P(0,0,0,0,0)(0) = 1.
We can now introduce a variant of Model 3.1, denoted Model 3.2, as done in Section 2.2, in which phos-
phorylation is not assumed to be instantaneous. In this case, the dimeric bound complexes, D2 and DM , can
become phosphorylated, P2 and PM , complexes, respectively. The complete set of reactions of Model 3.2 is given
in Figure 6. Non-null infinitesimal transition rates can be obtained in a similar way to Model 3.1 (see Eq. (8)),
and an analogous master equation to that in (9) can be written. An analogous procedure to the one described
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in SubSections 2.1 and 2.2 can be followed to study stochastic descriptors in these competition models. However,
the dimensionality of these processes makes them intractable from a computational point of view. Analytical
methods, such as moment-closure techniques, may be used, within the validity of these approximations, to study
the dynamics given in (9). We discuss the application of the Van Kampen approximation in Section 5, with a
short explanation of its implementation in Appendix D. However, given the restricted validity of the Van Kampen
approximation in our competition models, Gillespie simulations are also carried out in Section 4.
Figure 6: Reactions in Model 3.2. Reactions a)− b) are those of Figure 5. Reactions c)− f) describe the formation
of non-phosphorylated ligand cross-linked dimers. Reactions g) and h) represent, respectively, phosphorylation of
homodimers D2 and heterodimers DM .
2.4 Local sensitivity analysis for stochastic descriptors and kinetic rates
The objective of this Section is to develop a local sensitivity analysis to understand the effect that each of the
(binding, dissociation or phosphorylation) rates (α+, α−, β+, β−, γ+ and γ−) has on the stochastic descriptors
introduced in SubSections 2.1 and 2.2, in a given neighbourhood of parameter space. This selected neighbourhood
of parameter space may be obtained from a parameter estimation of in vitro and in silico experiments, as shown
in Section 3. Our aim then is to obtain the partial derivatives of our descriptors with respect to each parameter,
so that these derivatives provide a measure of the effect of a perturbation of the parameters on the descriptors.
Sensitivity analysis for CTMC with absorbing states has been recently developed in Ref. [22]. Although the
Markov chains considered in this paper are, in general, non-absorbing, the arguments in Ref. [22] can be clearly
generalised to the CTMCs considered here. We adapt them in what follows, while keeping the spirit of the matrix-
analytic approach.
For that aim, we consider a given matrix Am×n(θ), that depends on θ = (α+, α−, β+, β−, γ+, γ−), the parameter
vector, and its element by element derivative with respect to θi ∈ {α+, α−, β+, β−, γ+, γ−}, A(θi)(θ). It is then
possible to calculate the derivative of A−1(θ) with respect to θi from A(θi)(θ) as (see Refs. [30, 31])
(A−1)(θi)(θ) = −A−1(θ)A(θi)(θ)A−1(θ).
We have made use of this and other basic matrix calculus properties, as discussed in Ref. [22], to obtain Algorithm 1S
and Algorithm 2S, which are given in Appendix C, and can be obtained by sequentially differentiating all matrices in
Algorithm 1 and Algorithm 2, respectively. Finally, the explicit details of the element by element partial derivative
of the matrices defined in Appendix B, with respect to any parameter, θi ∈ {α+, α−, β+, β−, γ+, γ−}, have not
been included in Appendix B.
It is clear that, since our descriptors are stored in the vectors mN2,(l), mˆ(l) (time to reach a threshold number
of P2 complexes in Model 1 and Model 2, respectively) and quantities mj and mˆj (mean number of complexes in
steady state in Model 1 (j ∈ {1, 2}) and Model 2 (j ∈ {1, 2, 3}), respectively), the objective in Algorithm 1S and
Algorithm 2S is to obtain the derivative vectors mN2,(l,θi), mˆ(l,θi), pi(θi) and pˆi(θi). The first two vectors contain
the derivatives of the l-th order moments of the time to reach a given threshold number of P2 complexes, and the
last two yield the derivatives of quantities mj and mˆj , with respect to each rate θi ∈ {α+, α−, β+, β−, γ+, γ−}.
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3 Parameter estimation
In this Section we show how the parameters of the models introduced in Section 2 can be estimated, based on
the methods proposed by Lauffenburger and Linderman in Ref. [4]. The transport mechanism of free ligand or
free receptor is modelled by molecular diffusion, since diffusive transport dominates convective transport caused
by fluid motion at cellular and sub-cellular length scales [4, 32].
3.1 Model 1 and Model 2: single receptor (VEGFR1 or VEFGR2)
In this Section, we estimate the parameters for the binding and unbinding of a single type of receptor (VEGFR1
or VEGFR2) to VEGF-A. We denote the receptor molecule by R and the ligand by L. The binding process
between the receptor and the ligand, such as reaction a) in Figure 1, can be considered as a one-step process,
with kon the association constant and koff the dissociation constant. Constants kon and koff will be later identified
with or directly related to the rates α+ and α−, respectively, corresponding to the CTMCs under consideration in
Section 2 (Figures 1 and 2). However, chemical reactions such as binding and unbinding events, are in fact two-step
processes, requiring the ligand to move first into the neighbourhood of the receptor, with some diffusion rate kdL ,
and then interacting with it with intrinsic rate k3D+ [4]. The mechanism of the reverse process is similar, so that
the separation of the receptor and the ligand occurs with intrinsic dissociation rate k− and the outward diffusion
with transport rate kdL ; see Figure 7 a).
Figure 7: a) Two-step binding and unbinding of receptor and ligand. kdL is the ligand transport rate, k
3D
+ /k−
are the intrinsic binding/unbinding rates. b) Diffusive transport of surface receptor. kijd is the transport rate for
receptor Rj diffusing towards bound monomer Mi (if i = j, then k
ij
d = kdR). c) Once in the reaction zone of Mi,
Rj can bind with rate k
2D
+ (which is a 2D version of k
3D
+ ) or unbind with rate k−.
If we focus on a particular fraction 0 < f < 1 of the cell, as we will do in Section 4, the radius of this target
surface is given by
r =
√
nRsc
nTRpi
,
where sc is the total area of the cell surface, n
T
R is the total number of receptors on the cell surface, and nR = fn
T
R
is the number of receptors present on the target surface, which amounts to the assumption of an homogeneous
spatial distribution of VEGFR1 and VEGFR2 on the cell surface [33, 34], neglecting receptor clustering, which
might be initiated upon ligand simulation [35]. Then, the contributions of rates kdL , k
3D
+ and k− to the overall
association and dissociation rates, kon and koff , respectively, are given by
kon =
(
1
kdL
+
1
k3D+
)−1
, koff =
(
kdL
kdL + k
3D
+
)
k−, (10)
where the transport rate of the ligand is given by kdL =
4piDLr
nR
, with DL the diffusion coefficient of the ligand, so
that
kon =
4piDLrk
3D
+
4piDLr + nRk3D+
, koff =
4piDLrk−
4piDLr + nRk3D+
.
A similar argument (Figure 7 b) and c)) applies when computing the overall rate of a receptor binding or unbinding
to a second receptor on the cell membrane [4], which occurs with rates
kc =
(
1
kdR
+
1
k2D+
)−1
, ku =
(
kdR
kdR + k
2D
+
)
k−. (11)
Rate constants kc and ku will be later identified with or directly related to rates β+ and β−, respectively, for the
CTMCs considered in Section 2. In Eq. (11), we have
kdR =
2piDR
log wb
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is the transport rate of the free receptor (Figure 7 b)), DR is the diffusion coefficient of the receptor on the cell
membrane, b is the average radius of the receptor, and w is the average distance between the target receptor and
the diffusive free one, given by
w = 2
√
sc
pi nTR
.
We set the dissociation rate koff = 1.32 · 10−3s−1 as reported in Ref. [6], to be the same for VEGFR1 and
VEGFR2. From the equilibrium dissociation rate Kd = koff/(konNA) of the receptor and ligand under considera-
tion, where NA is Avogadro’s number, it is possible then to obtain kon. Given kon, transition rates α+ and α− in
Section 2 are given by
α+ =
kon
f h sc
, α− = koff ,
where h is the height of the experimental volume. Moreover, we can obtain k3D+ and k− from (10), which allows
us to compute kc and ku in (11). In particular, the intrinsic binding rate, k
3D
+ , (with units of s
−1 volume−1) is
obtained from (10) in a 3D version, and needs to be transformed into its 2D version, k2D+ , so that it can be used
in the expression (11). To that aim, we divide k3D+ by the average cell membrane thickness hm [4]. Once k
2D
+ and
k− have been computed, rates kc and ku are derived from (11) and
β+ =
kc
f sc
, β− = ku.
3.2 Model 3.1 and Model 3.2: two receptor types (VEGFR1 and VEFGR2)
In this Section we establish the value of the parameters for the competition Model 3.1 and Model 3.2. In this
case, there are two types of receptors (VEGFR1 and VEGFR2) in the system, R1 and R2, with the same diffusion
coefficient DR. Since the amount of each type of receptor on the cell surface is significantly different (see Section 4),
the average distance w between two given receptors, considered in the previous Section, will depend on the particular
pair of receptors under consideration. This changes the diffusion rate kdR of each possible reaction in Figures 5
and 6.
Let kijd be the transport rate for receptor Rj diffusing towards monomer Mi (Figure 7 b)), with i, j ∈ {1, 2}.
The probability of monomer Mi meeting receptor Rj can be approximated by
pj =
nTRj
nTR1 + n
T
R2
,
where nTRj is the total number of receptors Rj per cell. In the same way, the average distance between receptors
Ri and Rj can be written as
wij =
 2
√
sc
pi nTRi
, if i = j,
2
√
sc
pi (nTR1
+nTR2
)
, if i 6= j.
Finally, the diffusion rates are then given by
kijd =
{ 2piDR
log
wii
b
, if i = j,
2piDR
log
wij
b
pi, if i 6= j.
3.3 Sensitivity analysis for physiological parameters and kinetic rates
In this Section we are interested in studying how the key rates k3D+ , k−, kc, and ku depend on some of the other
parameters of the model. We note that these four constants are essential to describe the rates of the CTMCs
considered in this paper (see Figures 1, 3, 5 and 6). In particular, we analyse in what follows how these four kinetic
rates depend on physiological parameters such as the area sc of the cell, the total number n
T
R of receptors, the
ligand diffusion coefficient DL, the receptor diffusion coefficient DR, and the receptor radius b. We carry out a
sensitivity analysis which allows us to identify the most relevant parameter(s) of the model.
We obtain the partial derivatives of these four rates with respect to the physiological parameters. The effect of a
given parameter on a kinetic rate is determined by the sign of the corresponding partial derivative, which is reported
in Table 1. As the cell surface increases, it becomes more difficult to find nearby receptors, thus binding/unbinding
rates (intrinsic and overall) decrease. On the other hand, when the number of receptors increases, it is easier to find
nearby receptors, so that the association and dissociation rates are larger for increasing receptor numbers. If the
diffusion coefficient of the ligand increases, kdL also increases and thus, the intrinsic binding rate must decrease.
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Physiological parameter Sign of partial derivatives
Area of the cell surface, sc
∂k3D+
∂sc
, ∂k−∂sc ,
∂kc
∂sc
, ∂ku∂sc < 0
Total number of receptors, nTR
∂k3D+
∂nTR
, ∂k−
∂nTR
, ∂kc
∂nTR
, ∂ku
∂nTR
> 0
Diffusion coefficients, DL and DR
∂k3D+
∂DL
, ∂k−∂DL < 0,
∂kc
∂DR
, ∂ku∂DR > 0
Receptor radius, b ∂kc∂b ,
∂ku
∂b > 0
Table 1: Signs of partial derivatives.
Yet, if the diffusion coefficient of the ligand increases, the probability of dimerisation is greater, and overall rates
grow. Finally, by increasing the receptor length, the average time to find a free receptor decreases.
In order to compare the magnitudes of the different partial derivatives in Table 1, they need to be normalised by
the introduction of sensitivity coefficients. The sensitivity coefficient of a given dependent parameter with respect
to an independent one can be calculated from the corresponding partial derivative. Specifically, if a parameter y
depends on the parameter z as y = f(z), where f(·) is a certain function, we can define their associated sensitivity
coefficient as ∂y∂z
z∗
y∗ , where z
∗ is the actual value of the parameter z and y∗ = f(z∗). The quotient z
∗
y∗ is then
introduced to normalise the partial derivative. For example, let us focus on the partial derivatives of the binding
rate k3D+ . Given the definition of k
3D
+ , we have
k3D+ =
kon 4piDL
√
nR sc
nTR pi
4piDL
√
nR sc
nTR pi
− kon nR
,
and the following partial derivatives can be computed:
∂k3D+
∂DL
= −
k2on4pinR
√
nR sc
nT
R
pi
(4piDL
√
nR sc
nT
R
pi
−konnR)2
,
∂k3D+
∂nTR
=
k2on4piDL
√
nRsc
nT
R
pi
nR
2nTR(4piDL
√
nRsc
nT
R
pi
−konnR)2
,
∂k3D+
∂sc
= −
k2onnR4piDL
nR
nT
R
pi
2
√
nRsc
nT
R
pi
(4piDL
√
nRsc
nT
R
pi
−konnR)2
.
Then, regardless of the particular values of the parameters, it can be shown that∣∣∣∣∂k3D+∂DL DLk3D+
∣∣∣∣ > ∣∣∣∣∂k3D+∂nTR n
T
R
k3D+
∣∣∣∣ = ∣∣∣∣∂k3D+∂sc sck3D+
∣∣∣∣.
Similar arguments to the previous ones yield the following inequalities:∣∣∣∣ ∂k−∂DL DLk−
∣∣∣∣ > ∣∣∣∣∂k−∂nTR n
T
R
k−
∣∣∣∣ = ∣∣∣∣∂k−∂sc sck−
∣∣∣∣,∣∣∣∣∂kc/u∂DR DRkc/u
∣∣∣∣ > ∣∣∣∣∂kc/u∂nTR n
T
R
kc/u
∣∣∣∣ = ∣∣∣∣∂kc/u∂b bkc/u
∣∣∣∣ > ∣∣∣∣∂kc/u∂sc sckc/u
∣∣∣∣,
so that the diffusion coefficients, DL and DR, are the most sensitive physiological parameters in the binding and
dissociation rates, while the specific value of the area of the cell surface is the least sensitive one. We note that the
previous inequalities are obtained under the following assumptions:
• the binding rate is much smaller than the diffusion rate of the ligand
konnR << 4piDL
√
nR sc
nTR pi
,
• surface receptor density is low, b2pinR << sc, which also implies that the average distance between receptors
is larger than the length of the receptor, and
• the intrinsic binding rate is greater than the diffusion rate of the receptor, k2D+ > 2piDR.
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4 Results
First, we note that all the rates involved in Models 1, 2, 3.1 and 3.2 (Figures 1, 3, 5 and 6, respectively) and used
in this Section, have been obtained by following the approach described in Section 3, with physiological parameters
taken from the literature. In particular, physiological parameters are given in Table 2, and the computed rates
corresponding to Models 1, 2, 3.1 and 3.2 are given in Table 3 and Table 4. The equilibrium dissociation rate for
VEGF-A and VEGFR1, and for VEGF-A and VEGFR2, is equal to Kd = 30pM and Kd = 150pM, respectively,
as reported in Ref. [6]. These rates are consistent with previously reported values for in silico experiements [25],
and agree with experimentally determined values [36, 37, 38, 39]. Finally, the phosphorylation rate of the DM
complexes in Model 3.2 is taken to be γ21+ = 0.5γ22+, since only VEGFR2 is assumed to become phosphorylated
(we are neglecting VEGFR1 phosphorylation [27]), and de-phosphorylation rate of PM complexes is taken to be
γ21− = γ22−.
Physiological parameter Value Reference
Endothelial cell surface area, sc 1000 µm
2 [6]
VEGF-A diffusion coefficient at 4 ◦C, DL 5.8 · 10−7cm2s−1 [40]
VEGFR1 and VEGFR2 diffusion coefficient, DR 10
−10cm2s−1 [41]
VEGFR1 and VEGFR2 radius, b 0.5 nm [9]
Average membrane thickness of ECs, hm 0.1 µm [42]
Height of the experimental volume, h 1 mm [6]
Dissociation rate, koff 1.32 · 10−3s−1 [6]
Equilibrium dissociation rate, Kd for VEGFR1 30 pM [6]
Equilibrium dissociation rate, Kd for VEGFR2 150 pM [6]
Phosphorylation rate for D2 complexes, γ22+ 0.22 min
−1 [4]
De-phosphorylation rate for P2 complexes, γ22− 0.055 min−1 [4]
Table 2: Physiological parameters
α+ α− β+ β− γ+ γ−
3.653 · 10−7 1.320 · 10−3 2.160 · 10−4 7.804 · 10−5 3.667 · 10−3 9.167 · 10−4
Table 3: Kinetic rates (in s−1) for Model 1 and Model 2, where nR1 = 0, considering 4% of the cell. γ+ and γ−
are not considered in Model 1.
nR1 = 64 nR1 = 72 nR1 = 80
α1+ 1.827 · 10−6 1.827 · 10−6 1.827 · 10−6
α1− 1.320 · 10−3 1.320 · 10−3 1.320 · 10−3
α2+ 3.653 · 10−7 3.653 · 10−7 3.653 · 10−7
α2− 1.320 · 10−3 1.320 · 10−3 1.320 · 10−3
β11+ 2.074 · 10−4 2.091 · 10−4 2.105 · 10−4
β11− 1.499 · 10−5 1.511 · 10−5 1.521 · 10−5
β12+ 1.744 · 10−4 1.704 · 10−4 1.665 · 10−4
β12− 6.303 · 10−5 6.156 · 10−5 6.017 · 10−5
β21+ 5.039 · 10−5 5.530 · 10−5 5.997 · 10−5
β21− 3.642 · 10−6 3.996 · 10−6 4.333 · 10−6
β22+ 2.160 · 10−4 2.160 · 10−4 2.160 · 10−4
β22− 7.804 · 10−5 7.804 · 10−5 7.804 · 10−5
γ21+ 1.833 · 10−3 1.833 · 10−3 1.833 · 10−3
γ21− 9.167 · 10−4 9.167 · 10−4 9.167 · 10−4
γ22+ 3.667 · 10−3 3.667 · 10−3 3.667 · 10−3
γ22− 9.167 · 10−4 9.167 · 10−4 9.167 · 10−4
Table 4: Kinetic rates (in s−1) for Model 3.1 and Model 3.2 considering 4% of the cell. γ21+, γ21−, γ22+ and γ22−
are not considered in Model 3.1.
We consider in this Section the subset of endothelial cells, called human umbilical vein endothelial cells (HU-
VECs), which have been characterised to express (on average) 5800 VEGFR2s per cell [29]. We focus on a 4% of the
cell surface (f = 0.04) for computational reasons, so that in this area the total number of VEGFR2s is nR2 = 232.
We note that the size of the area under study is chosen so that the algorithms in Appendix C can be used in a
reasonable running time. However, computational demand of the Algorithms 1, 2, 1S and 2S for Model 1, and their
respective versions for Model 2, significantly differ from each other, so that the area under consideration could be
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eventually increased depending on the particular descriptor under study. In SubSection 4.1, our results correspond
to Models 1 and 3.1, where immediate phosphorylation is assumed. In SubSection 4.2 we develop an analogous
analysis for Models 2 and 3.2, where delayed phosphorylation is considered. For these models, our objective is to
analyse the dynamics of the different receptors and complexes for different VEGF-A ligand concentrations, and to
study the competition effect that the presence of VEGR1 has in the dynamics of VEGFR2. Finally, the sensitivity
analysis of the descriptors with respect to the kinetic rates is carried out in SubSection 4.3, following the arguments
provided in SubSection 2.4.
4.1 Immediate phosphorylation: Model 1 and Model 3.1
In Figure 8, we plot E[T(0,0)(N2)] for values 0 ≤ N2 ≤ nL, where nL ∈ {23, 58, 116} is the number of ligands
considered, which corresponds to 10%, 25% and 50% of the total number of VEGFR2, respectively, and to the
following ligand concentrations, cL ∈ {1pM, 2.5pM, 5pM}. The number of ligands considered in these three cases
verifies the condition 2nL ≤ nR2 , assumed in the analysis of T(0,0)(N2), as discussed in SubSection 2.1. T(0,0)(N2)
is the continuous random variable that represents the time to reach a total number, N2, of phosphorylated dimers
P2, given the initial state (0, 0), in Model 1 with instantaneous phosphorylation (for details, see SubSection 2.1).
The figures in this Section have been restricted to times up to 60 min, to describe the early time dynamics of the
cell surface. The long-term behaviour of the system can be analysed by means of the steady state distribution. In
Figure 8, solid curves represent values of E[T(0,0)(N2)] in the absence of VEGFR1; that is, these quantities have
been obtained in an exact way, making use of Algorithm 1 in Appendix C. Shaded areas have been obtained for
Model 1 (in the absence of VEGFR1) by considering E[T(0,0)(N2)]± SD[T(0,0)(N2)], where SD[X] represents the
standard deviation of the random variable X, which in the case of T(0,0)(N2) can be obtained from Algorithm 1
in Appendix C. On the other hand, dashed, dash-dotted and dotted curves correspond to values of E[T(0,0)(N2)]
when 64, 72 and 80 VEGFR1s are present in the area under study of the cell surface, respectively. These numbers
correspond to a total of 1600, 1800 and 2000 VEGFR1s on the cell surface. This choice is based on the fact that
HUVECs express a total number of 1800± 100 VEGFR1 receptors per cell [29]. In this case, these quantities have
been obtained making use of Gillespie simulations of Model 3.1.
Figure 8: E[T(0,0)(N2)] for (from left to right) ligand concentrations cL ∈ {1pM, 2.5pM, 5pM}. Solid curves
represent the descriptor in the absence of VEGFR1. Dashed, dash-dotted and dotted curves represent the descriptor
with 64, 72 and 80 numbers of VEGFR1s in the cell area under study, respectively.
In Figure 8, a monotonic behaviour can be easily identified. For a fixed value of N2, E[T(0,0)(N2)] is always
smaller for larger ligand concentrations, cL. Indeed, an increase in the amount of ligand available to bind receptors
will imply reaching the given signal threshold (encoded by the value of N2) in a shorter time. Our results indicate
that the presence of VEGFR1 changes the time to reach this threshold: absence of VEGFR1 (solid curves) and
different concentrations of VEGFR1 (dashed, dash-dotted and dotted lines). In particular, VEGFR1 is known to
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sequester ligands from VEGFR2 so that a delay in the formation of P2 complexes is observed. However, the effect
of VEGFR1 on the formation of phosphorylated dimers, P2, significantly differs for different ligand concentrations.
As can be seen in Figure 8, the time delay due to the presence of VEGFR1 increases as the amount of ligand
decreases. For example, when the ligand concentration is given by cL = 1pM , the mean time E[T(0,0)(N2)] to
reach a threshold N2 = 5 (20% of nL) of phosphorylated dimers is 24.99 min in the absence of VEGFR1. On the
other hand, these times approximately amount to 43.63, 58.97 and 83.36 min when the number of VEGFR1s is
64, 72 and 80, respectively. Thus, the time delay caused by the presence of VEGFR1, relative to the time in the
absence of VEGFR1 is 74.59%, 135.97% and 233.57%, respectively. If the ligand concentration is cL = 5pM , these
percentages are reduced to 40.56%, 48.74% and 58.19%, respectively. That is, the delay effect of VEGFR1 on the
formation of P2 complexes increases as the amount of ligand decreases, as expected, given that the competition
between VEGFR1 and VEGFR2 to bind ligand, slowly vanishes as the concentration of ligand increases. This
behaviour is still observed in Gillespie simulations when larger values of cL than those studied in Figure 8, are
considered.
The presence of VEGFR1 does not only affect the time scales for obtaining a given signal threshold, but it also
affects the maximum threshold N2 that is reached, which is the asymptotic behaviour observed in Figure 8. We
note that, although in principle any threshold N2 is achieved with probability 1 in our models in the long-term
1,
Gillespie simulations show that this asymptotic behaviour, which approaches a value, m2, corresponds to the steady
state value of the number of P2 complexes. Thresholds above the steady state value do not seem to be reached in
the time scale analysed in our simulations, so that the steady state value should become a representative value of
the signal threshold that can be obtained in a biologically reasonable time scale. This steady state distribution is
also significantly affected by the presence of VEGFR1. This distribution can be obtained in an exact way in the
absence of VEGFR1, by means of Algorithm 2 in Appendix C. In this case, with no VEGFR1, the mean number
m2 of P2 complexes in steady state is 22.10, 53.32, and 85.16 for ligand concentrations corresponding to values
cL = 1pM , 2.5pM and 5pM , respectively.
In order to analyse the dynamics of the stochastic process in the presence of VEGFR1, in Figure 9 we plot the
means and standard deviations of the random variables in Model 1 and Model 3.1 as a function of time. The time
course has been generated by means of Gillespie simulations, where we have broaden the VEGF-A concentration
range by considering nL ∈ {0.1nR2 , 0.25nR2 , 0.5nR2 , 10nR2 , 50nR2 , 100nR2 , 250nR2 , 625nR2 , 1250nR2}, which ap-
proximately corresponds to concentrations cL ∈ {1pM, 2.5pM, 5pM, 0.1nM, 0.5nM, 1nM, 2.5nM, 6.25nM, 12.5nM}.
For low ligand concentrations the number of dimers grows as the VEGF-A concentration is increased. For these
concentrations the steady state has not been reached in the first 60 min of the numerical simulation. However,
higher concentrations result in saturated situations, where the difference between the number of P2 complexes
with and without VEGFR1 becomes stable. In fact, this saturation results in lower numbers of P2 complexes for
ligand concentrations higher than cL ∼ 2.5nM . Thus, concentrations around 0.1nM − 2.5nM may be considered
as optimum ones. As mentioned above, for ligand concentrations of order cL = {6.25nM, 12.5nM}, the system
exhibits a reduction in the number of dimers, which is caused by the formation of monomeric bound complexes
(see Figure 9). In fact, by analysing the formation of monomers as a function of time, we observe, under optimum
ligand concentrations, a peak of monomeric complexes in the first 5 minutes, which is followed by a decrease to the
steady state values. For high ligand concentrations, the steady state value for monomeric complexes increases, so
that formation of dimers is effectively blocked. The inhibition of dimer formation at high ligand concentrations is
intrinsically related to the LID assumption, where the formation of free receptor pre-dimers is not allowed. If free
receptor dimers were to be considered, their effect would be negligible for ligand concentrations below 1nM [6].
4.2 Delayed phosphorylation: Model 2 and Model 3.2
In Figure 10, an analogous analysis to that of Figure 8 is carried out by means of adapted versions of Algorithm 1
and Algorithm 2 in Appendix C. In this case, we require the random variable T(0,0,0)(N3) which describes the
time to reach a total number, N3, of phosphorylated P2 complexes when delayed phosphorylation is assumed
(introduced in Model 2 and Model 3.2). The behaviour in Figure 10 is similar to that observed in Figure 8, so that
the consideration of delayed phosphorylation in the model does not seem to qualitatively affect the main features of
the descriptor under consideration. Therefore, the comments made in Figure 8 about the descriptor E[T(0,0)(N2)]
for different concentrations of ligand and VEGFR1 are also valid for Figure 10, but in this case for the descriptor
E[T(0,0,0)(N3)]. However, the consideration of phosphorylation as an independent reaction in the process clearly
amounts to a delay in the time to reach the threshold N3, when comparing it with the time to reach the threshold
N2 in Figure 8: every curve is displaced to the left. Finally, we have also computed the steady state distribution:
in the absence of VEGFR1 the mean number mˆ3 of P2 complexes in steady state is 18.25, 45.51 and 77.89, for
ligand concentrations cL = 1pM , 2.5pM and 5pM , respectively.
In Figure 11, we carry out Gillespie simulations to obtain the dynamics of the system in Model 3.2 for different
ligand concentrations, as before, cL ∈ {1pM, 2.5pM, 5pM, 0.1nM, 0.5nM, 1nM, 2.5nM, 6.25nM, 12.5nM}. For
high ligand concentrations, phosphorylation events occur within 10-20 minutes of ligand stimulation [1, 33, 8]. The
1 We are dealing with irreducible CTMCs defined over a finite number of states, so that the stochastic process allows to visit any
state in the CTMC, and thus to reach any signal threshold.
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Figure 9: Gillespie simulations of the process for different initial ligand concentrations cL ∈ {1pM, 2.5pM,
5pM, 0.1nM, 0.5nM, 1nM, 2.5nM, 6.25nM, 12.5nM}. Dashed lines correspond to Model 1 and solid lines corre-
spond to Model 3.1. Time course for monomers (top) and dimers (bottom).
number of non-active dimers (D1, DM , D2) is, in general, lower than the number of active dimers PM and P2, in
steady state. When enough ligand stimulation is given (cL ∈ {0.1nM, 0.5nM, 1nM, 2.5nM, 6.25nM, 12.5nM}) the
curves corresponding to dimers D2 andDM show a peak at early times, which is eventually lost once these complexes
become phosphorylated, as can be seen in the sudden increase for P2 and PM complexes. Similar comments can
be made regarding monomer formation (see Figure 11): a peak is seen during the first 5 minutes, slightly before
the dimeric peak. This clearly indicates a two-step (monomer and non-phosphorylated dimer) formation process,
which is required for the subsequent creation of phosphorylated complexes on the cell surface. The optimum ligand
concentration, cL, for phosphorylated dimers in steady state is approximately given by the range 0.1nM − 2.5nM .
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Figure 10: E[T(0,0,0)(N3)] for (from left to right) ligand concentrations cL ∈ {1pM, 2.5pM, 5pM}. Solid curves
represent the descriptor in the absence of VEGFR1. Dashed, dash-dotted and dotted curves represent the descriptor
with 64, 72 and 80 numbers of VEGFR1s in the cell area under study, respectively.
As depticted in Figure 9, for higher ligand concentrations monomeric complexes are more likely to be formed than
either non-phosphorylated or phosphorylated dimeric complexes. In this case, the peak for non-phosphorylated
dimers D2 and DM is reduced, which is explained by the larger numbers of monomeric bound complexed formed
(see Figure 11).
When focusing on the number of dimers at t = 60 min, we observe an approximately 20% decrease for the number
of P2 dimers in Model 2 with respect to Model 1, for small ligand concentrations cL ∈ {1pM, 2.5pM, 5pM}. As
cL grows, the difference between the number of P2 dimers drops down to 16%. However, additional numerical
results, not presented here, show that the ratio between phosphorylated P2 and non-phosphorylated D2 dimers in
Model 2 does not change with ligand concentration, and it is approximately 4 : 1. Finally, an additional aspect
we are interested in, is the influence of competition on the number of dimers. Our results indicate that there is
a 35% decrease in the number of P2 complexes in Model 3.1 with instantaneous phosphorylation for small ligand
concentration, cL = 1pM with respect to Model 1. As the ligand concentration increases, this difference drops
down to 22%, so that the competition between VEGFR1 and VEGFR2 is, again, reduced when enough ligand
stimulation is given. In the model with delayed phosphorylation, there is a 15% decrease in the number of dimers
P2 in Model 3.2 compared to Model 2, for small ligand concentration, cL = 1pM . As the concentration of ligand
is increased, this difference also drops down to 1− 2%.
4.3 Sensitivity analysis
Finally, the effect of the binding, dissociation and phosphorylation rates on the descriptors considered in this paper
(for phosphorylated P2 complexes), can be estimated by means of the sensitivity analysis proposed in Section 2.4.
In Table 5 we present the derivatives of the descriptors E[T(0,0)(N2)], E[T(0,0,0)(N3)], m2 and mˆ3, when N2 and N3
are chosen to be 25% of the total number of ligands nL, and for different concentrations of ligands cL. As expected,
the effect of each rate on any descriptor increases with increasing values of ligand concentration cL. However, we
note that the rate α+ is the most influential one (it seems to have twice the effect of any other rate), for all the
descriptors. Thus, we conclude that the formation of monomers seems to play here a more crucial role for the
formation of phosphorylated dimers than the phosphorylation or dimerisation rates themselves.
5 Discussion
In this paper, we have introduced different stochastic models to analyse the binding and phosphorylation dynamics
of VEGF-A/VEGFR2 and VEGF-A/VEGFR1 in vascular endothelial cells. Model 1 in Section 2.1 and Model 2 in
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Figure 11: Gillespie simulations of the process for different initial ligand concentrations cL ∈ {1pM, 2.5pM,
5pM, 0.1nM, 0.5nM, 1nM, 2.5nM, 6.25nM, 12.5nM}. Dashed lines correspond to Model 2 and solid lines corre-
spond to Model 3.2. Time course for monomers (top) and dimers (bottom).
Section 2.2 consider the following processes: ligand VEGF-A binds receptor VEGFR2 in order to form monomers
and dimers, which can eventually dissociate. Dimers become instantaneously phosphorylated in Model 1, while
in Model 2 phosphorylation is considered a new and independent reaction. In these two models, matrix-analytic
techniques have been applied to study the time to reach a threshold of phosphorylated dimers P2 on the cell
membrane, and the steady state distribution of the corresponding CTMCs. Moreover, the construction of Model 2,
as an extension of Model 1 in Section 2 allows us, not only to analyse the role played by phosphorylation events
(in Section 4), but also to show how different reactions may be incorporated while adapting the matrix-analytic
approach.
We note that, although our arguments in Section 2.1 and Section 2.2 might be adapted to include any number
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Partial Derivative cL α+ α− β+ β− γ+ γ−
∂E[T(0,0)(N2)]
∂θ 1pM −8.40× 107 6.85× 102 −5.79× 103 1.39× 103 − −
2.5pM −8.85× 107 7.77× 102 −6.50× 103 2.01× 103 − −
5pM −9.26× 107 9.00× 102 −7.54× 103 2.84× 103 − −
∂E[T(0,0,0)(N3)]
∂θ 1pM −8.85× 107 6.79× 102 −5.84× 103 1.03× 103 −2.34× 103 3.66× 103
2.5pM −9.96× 107 8.13× 102 −6.81× 103 1.39× 103 −3.08× 103 6.27× 103
5pM −1.10× 108 9.99× 102 −8.22× 103 1.93× 103 −3.75× 103 8.85× 103
∂m2
∂θ 1pM 2.09× 106 −5.78× 102 3.91× 103 −1.08× 104 − −
2.5pM 9.74× 106 −2.70× 103 1.77× 104 −4.90× 104 − −
5pM 2.41× 107 −6.66× 103 4.35× 104 −1.20× 105 − −
∂mˆ3
∂θ 1pM 3.65× 105 −1.01× 102 6.83× 102 −1.89× 103 1.03× 103 −4.11× 103
2.5pM 2.16× 106 −5.97× 102 3.90× 103 −1.08× 104 2.67× 103 −1.07× 104
5pM 1.25× 107 −3.47× 103 2.21× 104 −6.11× 104 5.29× 103 −2.12× 104
Table 5: Partial derivatives of the stochastic descriptors E[T(0,0)(N2)] and E[T(0,0,0)(N3)] (in
min
s−1 ) and descrip-
tors m2 and mˆ3 (in
molecules
s−1 ), with respect to each parameter θi ∈ {α+, α−, β+, β−, γ+, γ−} for different ligand
concentrations cL ∈ {1pM, 2.5pM, 5pM}.
of reactions, the computational efficiency of the algorithms would decrease with increasing number of reactions.
Thus, a balance between the complexity of the model and computational considerations is required, and numerical
approaches, such as moment-closure techniques or Gillespie simulations, may always prevail for more complex
models. In particular, Model 3.1 and Model 3.2 in Section 2.3, which incorporate the competition between VEGFR1
and VEGFR2 for ligand availability, do not seem to be computationally effective when adapting procedures from
Section 2.1 and Section 2.2. In light of this, Gillespie simulations have been carried out in Section 4 when dealing
with these models.
A particular assumption in our models of Section 2 is that dissociation of phosphorylated dimers requires de-
phosphorylation as a first step. For comparison, we introduce a more general model that allows ligand-dissociation
of phosphorylated dimers. Three new reactions have been added to Model 2 and Model 3.2 in order to consider
the dissociation of phosphorylated dimers: P2
β22−−→ R2 + M2, PM β21−−→ R2 + M1 and PM β12−−→ R1 + M2. We have
assumed that the previous ligand-dissociation reactions also imply de-phosphorylation of the receptors, and thus,
no phosphorylated monomeric receptors are allowed, which in turn, could bind ligand in a subsequent reaction.
This can be justified as de-phosphorylation is a fast process (see Table 2). The results are shown in Figure 12, where
the most significant difference with respect to Figure 11 is the slow decay that can be observed for the number of
P2 complexes after 20 minutes under optimum ligand concentrations. This small effect, which is more prominent in
Model 2 than in Model 3.2, can be explained by the new de-phosphorylation pathway of P2 complexes (by ligand
dissociation). This clearly indicates a two-step (monomer and non-phosphorylated dimer) formation process, which
is required for the subsequent creation of phosphorylated dimers on the cell surface (P2 and PM complexes).
However, no other significant differences can be identified with the introduction of these three new reactions (see
Figure 11 and Figure 12). This suggests that the the additional reactions do not qualitatively change the dynamics
or the steady state of the system, with or without VEGFR1.
Alternative approaches, such as moment-closure techniques, when analysing the master equation in Eq. (9),
are available for our models. In particular, we have also analysed Model 3.1 and Model 3.2 making use of the
van Kampen approximation, which is briefly described in Appendix D. The van Kampen approximation, as well
as any other moment-closure method, aims to obtain the time evolution of the different order moments for the
random variables of the CTMCs under consideration. In particular, and as shown in Eq. (9), it is possible to obtain
a system of differential equations for the different order moments of the random variables considered. However,
this system of differential equations relates any order moment of a variable X(t) to its immediately posterior
order moment, which yields an infinite system of differential equations. The main assumption of the van Kampen
approximation is that the distribution of the stochastic fluctuations around a steady state follows a multi-variate
normal distribution, which allows to close the order moment hierarchy. Furthermore, one can also evaluate the
accuracy of this approximation by means of the covariance matrix of these random variables and the locus (contour)
of constant probability [43]. This contour is the set of values of the random variables for which their joint probability
density function is greater or equal to some constant K. Then, when we consider, for example, two given random
variables of the process, the probability, pˆ, of a realisation of this bi-dimensional random vector to be in the contour
of constant probability (of constant value K) can be obtained from the χ-square distribution by pˆ = 1−exp(−K/2).
As the random variables in Models 3.1 and Model 3.2 represent numbers of complexes for different molecu-
lar species, we should only focus on non-negative values for these random variables. Therefore, given any two
molecular species, we need to restrict the confidence ellipses, corresponding to large enough values of pˆ, to be
on the first quadrant. In Figure 13 and for Model 3.1, we plot the contours corresponding to the numbers P2
of VEGFR2 homodimers and PM of heterodimers, in steady state, for ligand concentrations cL ∈ {1pM, 2.5pM,
5pM, 0.1nM, 0.5nM, 1nM, 2.5nM, 6.25nM, 12.5nM}. These contours correspond to a probability p = min{0.99, pˆ},
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Figure 12: Generalisation of Model 2 and Model 3.2 to include ligand dissociation of phosphorylated dimers. This
figure is analogous to Figure 11.
where pˆ is the maximum probability that yields a contour within the first quadrant, so that 0.99 is identified here
with a proper performance of the approximation method. When considering low concentrations, the probability p
increases until it reaches its maximum value p = 0.99 for cL = 5pM , which corresponds to a number of ligands which
is of the same order than the total number of receptors nR2 . The performance of the van Kampen approximation
clearly improves with increasing values of cL, which is reflected in the smaller contours obtained amounting to a
total probability mass of 0.99. These results are consistent with the fact that, under larger ligand concentrations,
the behaviour of the stochastic process can be properly approximated by its deterministic counterpart. On the
other hand, under low ligand concentrations, the van Kampen approach can not properly reflect the stochasticity
in the system (p = 0.49 for cL = 1pM in Figure 13).
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Figure 13: Ellipse contours in Model 3.1, for initial ligand concentrations cL ∈ {1pM, 2.5pM,
5pM, 0.1nM, 0.5nM, 1nM, 2.5nM, 6.25nM, 12.5nM}. These ellipse contours correspond to p = min{0.99, pˆ}, where
pˆ is the maximum probability that yields a contour in the the first quadrant.
The numerical results presented in Section 4 have allowed us to quantify the effect of different ligand con-
centrations and different concentrations of the competitor VEGFR1 on the dynamics of the process. Increasing
ligand concentration compensates the competition effect caused by the presence of VEGFR1, but at the same time
too high ligand concentrations can result in saturated situations, where the phosphorylation of dimers is reduced
and monomeric bound complexes are enhanced. We also note that the total number of VEGFR2s per cell varies
according to Refs. [44, 33, 37] and could be tenfold higher than used in our computations [29]. A larger num-
ber of VEGFR2s on the cell surface would, however, only quantitatively change our results: a reduced VEGFR1
competition effect and a higher optimum ligand concentration. Finally, the sensitivity analysis carried out for the
descriptors enables us to show how the monomeric formation rate, α+, plays a crucial role in these models, with
an effect which is twice the effect of any other rate for any of the descriptors we have considered.
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Appendix A. Notation
In this appendix we set some standard notation we use throughout the paper. First of all, δi,j represents
Kronecker’s delta, that is,
δi,j =
{
1, if i = j,
0, otherwise.
Given a set S, # represents its cardinality. Regarding matrix notation, matrices and vectors are always given in
bold, where 0p (eq) represents a column vector of zeros (ones) with dimension p (q). The symbol
T represents the
transposition operator and, for a matrix A(θ), we use the calculus notation
A(l)(0) =
dl
dθl
A(θ)
∣∣∣∣
θ=0
.
Finally, when a matrix depends on different parameters, A(α, θ), its first order partial derivatives with respect to
each parameter are given by A(α)(α, θ) and A(θ)(α, θ), respectively.
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Appendix B. Matrices introduced in Section 2
B.1. Matrices Ak,k′ in (2)
Matrices Ak,k′ in (2) contain the infinitesimal transition rates for those transitions from states in level L(k) to
states in level L(k′), for k′ ∈ {k − 1, k, k + 1}, and are obtained from (1) as follows:
• For 1 ≤ k ≤ nL,
(Ak,k−1)ij =
{
2β−k, if j = i+ 1,
0, otherwise,
where 0 ≤ i ≤ nL − k, 0 ≤ j ≤ nL − k + 1.
• For 0 ≤ k ≤ nL,
(Ak,k)ij =

2α+(nR2 − i− 2k)(nL − i− k), if j = i+ 1,
α−i, if j = i− 1,
− (2α+(nR2 − i− 2k)(nL − i− k) + α−i+ 2β−k + β+i(nR2 − i− 2k)) ,
if j = i,
0, otherwise,
where 0 ≤ i ≤ nL − k, 0 ≤ j ≤ nL − k.
• For 0 ≤ k ≤ nL − 1,
(Ak,k+1)ij =
{
β+i(nR2 − i− 2k), if j = i− 1,
0, otherwise,
where 0 ≤ i ≤ nL − k, 0 ≤ j ≤ nL − k − 1.
B.2. Sub-matrices Ak,k′(z) and sub-vector aN2−1(z) in (4)
Sub-matrices Ak,k′(z) and sub-vector aN2−1(z) in (4) are given by:
• (aN2−1(z))i = β+i(nR2−i−2(N2−1))z+A(i,N2−1) , for 0 ≤ i ≤ nL −N2 + 1.
• For 1 ≤ k ≤ nL,
(Ak,k−1(z))ij =
{
2β−k
z+A(i,k)
, if j = i+ 1,
0, otherwise,
where 0 ≤ i ≤ nL − k, 0 ≤ j ≤ nL − k + 1.
• For 0 ≤ k ≤ nL,
(Ak,k(z))ij =

2α+(nR2−i−2k)(nL−i−k)
z+A(i,k)
, if j = i+ 1,
α−i
z+A(i,k)
, if j = i− 1,
0, otherwise,
where 0 ≤ i ≤ nL − k, 0 ≤ j ≤ nL − k.
• For 0 ≤ k ≤ nL − 1,
(Ak,k+1(z))ij =
{
β+i(nR2−i−2k)
z+A(i,k)
, if j = i− 1,
0, otherwise,
where 0 ≤ i ≤ nL − k, 0 ≤ j ≤ nL − k − 1.
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B.3. Derivative matrices AN2,(p)(0) and aN2,(p)(0) in (6)
Matrices AN2,(p)(0) and aN2,(p)(0) in (6) are given by
AN2,(p)(0) =

A
(p)
0,0(0) A
(p)
0,1(0) 0J(0)×J(2) . . . 0J(0)×J(N2−2) 0J(0)×J(N2−1)
A
(p)
1,0(0) A
(p)
1,1(0) A
(p)
1,2(0) . . . 0J(1)×J(N2−2) 0J(1)×J(N2−1)
0J(2)×J(0) A
(p)
2,1(0) A
(p)
2,2(0) . . . 0J(2)×J(N2−2) 0J(2)×J(N2−1)
...
...
...
. . .
...
...
0J(N2−2)×J(0) 0J(N2−2)×J(1) 0J(N2−2)×J(2) . . . A
(p)
N2−2,N2−2(0) A
(p)
N2−2,N2−1(0)
0J(N2−1)×J(0) 0J(N2−1)×J(1) 0J(N2−1)×J(2) . . . A
(p)
N2−1,N2−2(0) A
(p)
N2−1,N2−1(0)

,
aN2,(p)(0) =

0J(0)
0J(1)
...
0J(N2−2)
a
(p)
N2−1(0)
 ,
where expressions for a
(p)
N2−1(0) and A
(p)
k,k′(0) are as follows:
•
(
a
(p)
N2−1(0)
)
i
= (−1)pp!β+i(nR2−i−2(N2−1))
Ap+1
(i,N2−1)
, for 0 ≤ i ≤ nL −N2 + 1, p ≥ 1.
• For 1 ≤ k ≤ nL, p ≥ 1, (
A
(p)
k,k−1(0)
)
ij
=
{
(−1)pp! 2β−k
Ap+1
(i,k)
, if j = i+ 1,
0, otherwise,
where 0 ≤ i ≤ nL − k, 0 ≤ j ≤ nL − k + 1.
• For 0 ≤ k ≤ nL, p ≥ 1,
(
A
(p)
k,k(0)
)
ij
=

(−1)pp! 2α+(nR2−i−2k)(nL−i−k)
Ap+1
(i,k)
, if j = i+ 1,
(−1)pp! α−i
Ap+1
(i,k)
, if j = i− 1,
0, otherwise,
where 0 ≤ i ≤ nL − k, 0 ≤ j ≤ nL − k.
• For 0 ≤ k ≤ nL − 1, p ≥ 1,(
A
(p)
k,k+1(0)
)
ij
=
{
(−1)pp!β+i(nR2−i−2k)
Ap+1
(i,k)
, if j = i− 1,
0, otherwise,
where 0 ≤ i ≤ nL − k, 0 ≤ j ≤ nL − k − 1.
B.4. Matrices Aˆk,k′ in Model 2
For 0 ≤ k ≤ nL
Aˆk,k =

Bk,k0,0 B
k,k
0,1 0 . . . 0 0
Bk,k1,0 B
k,k
1,1 B
k,k
1,2 . . . 0 0
0 Bk,k2,1 B
k,k
2,2 . . . 0 0
...
...
...
. . .
...
...
0 0 0 . . . Bk,knL−k−1,nL−k−1 B
k,k
nL−k−1,nL−k
0 0 0 . . . Bk,knL−k,nL−k−1 B
k,k
nL−k,nL−k

,
for 0 ≤ k ≤ nL − 1,
Aˆk,k+1 =

0 0 0 . . . 0 0
Bk,k+11,0 0 0 . . . 0 0
0 Bk,k+12,1 0 . . . 0 0
...
...
...
. . .
...
...
0 0 0 . . . 0 0
0 0 0 . . . Bk,k+1nL−k,nL−k−1 0

,
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and, for 1 ≤ k ≤ nL,
Aˆk,k−1 =

0 Bk,k−10,1 0 . . . 0 0
0 0 Bk,k−11,2 . . . 0 0
0 0 0 . . . 0 0
...
...
...
. . .
...
...
0 0 0 . . . Bk,k−1nL−k−1,nL−k 0
0 0 0 . . . 0 Bk,k−1nL−k,nL−k+1

.
We note that, although we are omitting the dimensions of the matrices 0 for the ease of notation, the dimension
of each matrix 0, representing transitions from states in sub-level l(k; r) to states in sub-level l(k′; r′), is J(k; r)×
J(k′; r′). The expressions for the matrices Bk,k
′
r,r′ are given as follows:
• For 0 ≤ r ≤ nL − k, 0 ≤ k ≤ nL,
(
Bk,kr,r
)
ij
=

α−i, if j = i− 1,
−A(i,r,k), if j = i,
2α+(nR2 − i− 2r − 2k)(nL − i− r − k), if j = i+ 1,
0, otherwise,
where 0 ≤ i ≤ nL − r− k, 0 ≤ j ≤ nL − r− k, and, from now on, A(i,r,k) = 2α+(nR2 − i− 2r− 2k)(nL − i−
r − k) + α−i+ β+i(nR2 − i− 2r − 2k) + 2β−r + γ+r + γ−k.
• For 0 ≤ r ≤ nL − k − 1, 0 ≤ k ≤ nL,(
Bk,kr,r+1
)
ij
=
{
β+i(nR2 − i− 2r − 2k), if j = i− 1,
0, otherwise,
where 0 ≤ i ≤ nL − r − k, 0 ≤ j ≤ nL − r − k − 1.
• For 1 ≤ r ≤ nL − k, 0 ≤ k ≤ nL, (
Bk,kr,r−1
)
ij
=
{
2β−r, if j = i+ 1,
0, otherwise,
where 0 ≤ i ≤ nL − r − k, 0 ≤ j ≤ nL − r − k + 1.
• For 1 ≤ r ≤ nL − k, 0 ≤ k ≤ nL − 1,(
Bk,k+1r,r−1
)
ij
=
{
γ+r, if j = i,
0, otherwise,
where 0 ≤ i ≤ nL − r − k, 0 ≤ j ≤ nL − r − k.
• For 0 ≤ r ≤ nL − k, 1 ≤ k ≤ nL, (
Bk,k−1r,r+1
)
ij
=
{
γ−k, if j = i,
0, otherwise,
where 0 ≤ i ≤ nL − r − k, 0 ≤ j ≤ nL − r − k.
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Appendix C. Algorithms
Algorithm 1 (to obtain the Laplace-Stieltjes transforms gN2(z) and the l-th order moments mN2,(l))
PART 1
HN20 (z) = IJ(0) −A0,0(z);
For k = 1, . . . , N2 − 1:
HN2k (z) = IJ(k) −Ak,k(z)−Ak,k−1(z)HN2k−1(z)−1Ak−1,k(z);
gN2N2−1(z) = H
N2
N2−1(z)
−1aN2−1(z);
m
N2,(0)
N2−1 = g
N2
N2−1(0);
For k = N2 − 2, . . . , 1, 0:
gN2k (z) = H
N2
k (z)
−1Ak,k+1(z)gN2k+1(z);
m
N2,(0)
k = g
N2
k (0);
PART 2
m
N2,(0)
N2−1 = g
N2
N2−1(0);
For k = N2 − 2, . . . , 1, 0:
m
N2,(0)
k = g
N2
k (0);
For p = 1, . . . , l:
P
N2,(p)
0 =
p∑
k=1
(
p
k
)
(−1)k
(
A
(k)
0,0(0)m
N2,(p−k)
0 +A
(k)
0,1(0)m
N2,(p−k)
1
)
;
For j = 1, . . . , N2 − 1:
P
N2,(p)
j = Aj,j−1(0)H
N2
j−1(0)
−1PN2,(p)j−1 +
p∑
k=1
(
p
k
)
(−1)k
(
A
(k)
j,j−1(0)m
N2,(p−k)
j−1
+A
(k)
j,j (0)m
N2,(p−k)
j + (1− δj,N2−1)A(k)j,j+1(0)mN2,(p−k)j+1
)
;
m
N2,(p)
N2−1 = H
N2
N2−1(0)
−1
(
P
N2,(p)
N2−1 + (−1)pa
(p)
N2−1(0)
)
;
For j = N2 − 2, . . . , 1, 0:
m
N2,(p)
j = H
N2
j (0)
−1
(
P
N2,(p)
j +Aj,j+1(0)m
N2,(p)
j+1
)
;
Algorithm 2 (to obtain the stationary distribution pi)
H0 = A0,0;
For k = 1, . . . , nL − 1:
Hk = Ak,k −Ak,k−1H−1k−1Ak−1,k;
pi∗nL = 1;
For k = nL − 1, . . . , 0:
pi∗k = − pi∗k+1Ak+1,kH−1k ;
For k = 0, . . . , nL:
pik =
1
nL∑
j=0
pi∗jeJ(r)
pi∗k;
Algorithm 1S (to obtain the derivative of the r-th order moments E[T(n1,n2)(N2)
r] with respect
θi ∈ {α+, α−, β+, β−})
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H
N2,(θi)
0 (0) = −A(θi)0,0 (0);
For k = 1, . . . , N2 − 1:
H
N2,(θi)
k (0) = −A(θi)k,k (0)−
(
A
(θi)
k,k−1(0)H
N2
k−1(0)
−1Ak−1,k(0)−Ak,k−1(0)HN2k−1(0)−1
×HN2,(θi)k−1 (0)HN2k−1(0)−1Ak−1,k(0) +Ak,k−1(0)HN2k−1(0)−1A(θi)k−1,k(0)
)
;
m
N2,(0,θi)
N2−1 = −HN2N2−1(0)−1H
N2,(θi)
N2−1 (0)H
N2
N2−1(0)
−1aN2−1(0) +H
N2
N2−1(z)
−1a,(θi)N2−1(z);
For k = N2 − 2, . . . , 1, 0:
m
N2,(0,θi)
k = −HN2k (0)−1HN2,(θi)k (0)HN2k (0)−1Ak,k+1(0)mN2,(0)k+1 +HN2k (0)−1A(θi)k,k+1(0)
×mN2,(0)k+1 +HN2k (0)−1Ak,k+1(0)mN2,(0,θi)k+1 ;
For j = 1, . . . , r:
P
N2,(j,θi)
0 =
j∑
k=1
(
j
k
)
(−1)k
(
A
(k,θi)
0,0 (0)m
N2,(j−k)
0 +A
(k)
0,0(0)m
N2,(j−k,θi)
0 +A
(k,θi)
0,1 (0)m
N2,(j−k)
1
+A
(k)
0,1(0)m
N2,(j−k,θi)
1
)
;
For p = 1, . . . , N2 − 1:
P
N2,(j,θi)
p = A
(θi)
p,p−1(0)H
N2
p−1(0)
−1PN2,(j)p−1 −Ap,p−1(0)HN2p−1(0)−1HN2,(θi)p−1 (0)
×HN2p−1(0)−1PN2,(j)p−1 +Ap,p−1(0)HN2p−1(0)−1PN2,(j,θi)p−1 +
j∑
k=1
(
i
k
)
(−1)k
×
(
A
(k,θi)
p,p−1(0)m
N2,(j−k)
p−1 +A
(k)
p,p−1(0)m
N2,(j−k,θi)
p−1 +A
(k,θi)
p,p (0)m
N2,(j−k)
p
+A
(k)
p,p(0)m
N2,(j−k,θi)
p + (1− δp,N2−1)
(
A
(k,θi)
p,p+1(0)m
N2,(j−k)
p+1 +A
(k)
p,p+1(0)
×mN2,(j−k,θi)p+1
))
;
m
N2,(j,θi)
N2−1 = −HN2N2−1(0)−1H
N2,(θi)
N2−1 (0)H
N2
N2−1(0)
−1
(
P
N2,(j)
N2−1 + (−1)ja
,(j)
N2−1(0)
)
+HN2N2−1(0)
−1
(
P
N2,(j,θi)
N2−1 + (−1)ja
,(j,θi)
N2−1 (0)
)
;
For p = N2 − 2, . . . , 1, 0:
m
N2,(j,θi)
p = −HN2p (0)−1HN2,(θi)p (0)HN2p (0)−1
(
P
N2,(j)
p +Ap,p+1(0)m
N2,(j)
p+1
)
+HN2p (0)
−1
×
(
P
N2,(j,θi)
p +A
(θi)
p,p+1(0)m
N2,(j)
p+1 +Ap,p+1(0)m
N2,(j,θi)
p+1
)
;
We point out that m
N2,(r,θi)
k and A
(r,θi)
k,k′ (0) in Algorithm 1S, which corresponds to the model with instanta-
neous phosphorylation, represent the derivatives of m
N2,(r)
k and A
(r)
k,k′(0), respectively, with respect θi, for θi ∈
{α+, α−, β+, β−}.
Algorithm 2S (to obtain the derivative of m1 and m2 with respect θi ∈ {α+, α−, β+, β−})
H
(θi)
0 = A
(θi)
0,0 ;
For k = 1, . . . , nL − 1:
H
(θi)
k = A
(θi)
k,k −
(
A
(θi)
k,k−1H
−1
k−1Ak−1,k −Ak,k−1H−1k−1H(θi)k−1H−1k−1Ak−1,k +Ak,k−1H−1k−1A(θi)k−1,k
)
;
pi
∗,(θi)
nL = 0;
For k = nL − 1, . . . , 1, 0:
pi
∗,(θi)
k = −
(
pi
∗,(θi)
k+1 Ak+1,kH
−1
k + pi
∗
k+1A
(θi)
k+1,kH
−1
k − pi∗k+1Ak+1,kH−1k H(θi)k H−1k
)
;
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For k = 0, . . . , nL:
pi
(θi)
k =
1
pi∗e#S
(
pi
∗,(θi)
k − pikpi∗,(θi)e#S
)
;
m
(θi)
1 =
nL∑
k=0
k
(
nL∑
j=0
(pi
(θi)
j )k
)
;
m
(θi)
2 =
nL∑
k=0
k
(
pi
(θi)
k eJ(k)
)
;
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Appendix D. van Kampen approximation
We have made use of the system-size expansion technique, based on the power series approximation proposed by
van Kampen [15], to study (9). In this Appendix, and for completeness, we derive the equations for the moments,
which will be used for numerical simulations.
We first identify the expansion parameter Ω, with Ω 1. In our study Ω represents the volume of the system,
so that fluctuations are of order Ω
1
2 . We write any discrete variable ni as a sum of “mean” number of particles of
type i (xi - macroscopic concentration) and fluctuations ξi of order Ω
1
2 : ni = Ωxi + Ω
1
2 ξi. This transformation of
variables implies
Pn(t) −→ Ψ(ξ, t), Ω 12 ∂
∂ni
Pn(t) =
∂
∂ξi
Ψ(ξ, t).
Therefore the left-hand-side of the master equation (9) might be rewritten as
dPn(t)
dt
=
∂Ψ
∂t
+
∑
i
∂Ψ
∂ξi
dξi
dt
. (12)
Our choice of transformation implies
dξi
dt
= −Ω 12 dxi
dt
,
so that we can write
dPn(t)
dt
=
∂Ψ
∂t
− Ω 12
∑
i
∂Ψ
∂ξi
dxi
dt
. (13)
The system of ODES for the mean variables xi is obtained from the term
∑
i
∂Ψ
∂ξi
dxi
dt
of equation (13) and the
system of ODEs for the moments of the fluctuations is obtained from the term
∂Ψ
∂t
of the equation (13). If we
collect all terms of order Ω0, we obtain the following Fokker-Planck equation
∂Ψ
∂t
= −
∑
i,j
Aij
∂
∂ξi
(ξjΨ) +
1
2
∑
i,j
Bij
∂2Ψ
∂ξi∂ξj
.
From the Fokker-Plank equation it is possible to obtain equations for the mean, the variance and the covariance
of the fluctuations
dE(ξi)
dt
=
∑
j
AijE(ξj),
dE(ξiξj)
dt
=
∑
k
AikE(ξkξj) +
∑
k
AjkE(ξiξk) +Bij .
van Kampen approximation for Model 3.1 In the case of Model 3.1 the deterministic variables are given by
(M1,M2, D1, P2, PM ) ∼ (x1, x2, x3, x4, x5).
The following parameters have been rescaled:
nL = NLΩ, nR1 = NR1Ω, nR2 = NR2Ω, α1+ = a1+Ω
−1, α2+ = a2+Ω−1,
β11+ = b11+Ω
−1, β12+ = b12+Ω−1 β21+ = b21+Ω−1, β22+ = b22+Ω−1.
The deterministic equations of Model 3.1 are given by
dx1
dt
= 2a1+(NR1 − x1 − 2x3 − x5)(NL − x1 − x2 − x3 − x4 − x5)
− b11+x1(NR1 − x1 − 2x3 − x5)− b12+x1(NR2 − x2 − 2x4 − x5)
− α1−x1 + 2β11−x3 + β12−x5,
dx2
dt
= 2a2+(NR2 − x2 − 2x4 − x5)(NL − x1 − x2 − x3 − x4 − x5)
− b22+x2(NR2 − x2 − 2x4 − x5)− b21+x2(NR1 − x1 − 2x3 − x5)
− α2−x2 + 2β22−x4 + β21−x5,
dx3
dt
= −2β11−x3 + b11+x1(NR1 − x1 − 2x3 − x5),
dx4
dt
= b22+x2(NR2 − x2 − 2x4 − x5)− 2β22−x4,
dx5
dt
= b12+x1(NR2 − x2 − 2x4 − x5) + b21+x2(NR1 − x1 − 2x3 − x5)− β12−x5 − β21−x5.
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We will denote by (x∗1, x
∗
2, x
∗
3, x
∗
4, x
∗
5) the unique stable steady state solution of Eqs. (14).
The coefficients Aij and Bij = Bji for the competition model with immediate phosphorylation (Model 3.1) are
Aij = 0 and Bij = 0, except for the following
A11 = −2a1+{(NL − x∗1 − x∗2 − x∗3 − x∗4 − x∗5) + (NR1 − x∗1 − 2x∗3 − x∗5)}
− b11+(NR1 − x∗1 − 2x∗3 − x∗5)− b12+(NR2 − x∗2 − 2x∗4 − x∗5) + b11+x∗1 − α1−,
A12 = b12+x
∗
1 − 2a1+(NR1 − x∗1 − 2x∗3 − x∗5),
A13 = −2a1+{2(NL − x∗1 − x∗2 − x∗3 − x∗4 − x∗5) + (NR1 − x∗1 − 2x∗3 − x∗5)}+ 2b11+x∗1 + 2β11−,
A14 = 2b12+x1 − 2a1+(NR1 − x∗1 − 2x∗3 − x∗5),
A15 = b11+x
∗
1 + b12+x
∗
1 + β12− − 2a1+{(NL − x∗1 − x∗2 − x∗3 − x∗4 − x∗5) + (NR1 − x∗1 − 2x∗3 − x∗5)},
A21 = b21+x
∗
2 − 2a2+(NR2 − x∗2 − 2x∗4 − x∗5),
A22 = −2a2+{(NL − x∗1 − x∗2 − x∗3 − x∗4 − x∗5) + (NR2 − x∗2 − 2x∗4 − x∗5)}
− b21+(NR1 − x∗1 − 2x∗3 − x∗5)− b22+(NR2 − x∗2 − 2x∗4 − x∗5) + b22+x∗2 − α2−,
A23 = 2b21+x
∗
2 − 2a2+(NR2 − x∗2 − 2x∗4 − x∗5),
A24 = −2a2+{2(NL − x∗1 − x∗2 − x∗3 − x∗4 − x∗5) + (NR2 − x∗2 − 2x∗4 − x∗5)}+ 2b22+x∗2 + 2β22−,
A25 = −2a2+{(NL − x∗1 − x∗2 − x∗3 − x∗4 − x∗5) + (NR2 − x∗2 − 2x∗4 − x∗5)}+ b21+x∗2 + b22+x∗2 + β21−,
A31 = b11+(NR1 − x∗1 − 2x∗3 − x∗5)− b11+x∗1,
A33 = −2b11+x∗1 − 2β11−,
A35 = −b11+x∗1,
A42 = b22+(NR2 − x∗2 − 2x∗4 − x∗5)− b22+x∗2,
A44 = −2b22+x∗2 − 2β22−,
A45 = −b22+x∗2,
A51 = −b21+x∗2 + b12+(NR2 − x∗2 − 2x∗4 − x∗5),
A52 = −b12+x∗1 + b21+(NR1 − x∗1 − 2x∗3 − x∗5),
A53 = −2b21+x∗2,
A54 = −2b12+x∗1,
A55 = −b12+x∗1 − b21+x∗2 − β12− − β21−,
B11 = 2a1+(NL − x∗1 − x∗2 − x∗3 − x∗4 − x∗5)(NR1 − x∗1 − 2x∗3 − x∗5) + b11+x∗1(NR1 − x∗1 − 2x∗3 − x∗5)
+ b12+x
∗
1(NR2 − x∗2 − 2x∗4 − x∗5) + α1−x∗1 + 2β11−x∗3 + β12−x∗5,
B13 = −2b11+x∗1(NR1 − x∗1 − 2x∗3 − x∗5)− 4β11−x∗3,
B15 = −2b12+x∗1(NR2 − x∗2 − 2x∗4 − x∗5)− 2β12−x∗5,
B22 = 2a2+(NL − x∗1 − x∗2 − x∗3 − x∗4 − x∗5)(NR2 − x∗2 − 2x∗4 − x∗5) + b21+x∗2(NR1 − x∗1 − 2x∗3 − x∗5)
+ b22+x
∗
2(NR2 − x∗2 − 2x∗4 − x∗5) + α2−x∗2 + β21−x∗5 + 2β22−x∗4,
B24 = −2b22+x∗2(NR2 − x∗2 − 2x∗4 − x∗5)− 4β22−x∗4,
B25 = −2b21+x∗2(NR1 − x∗1 − 2x∗3 − x∗5)− 2β21−x∗5,
B33 = b11+x
∗
1(NR1 − x∗1 − 2x∗3 − x∗5) + 2β11−x∗3,
B44 = b22+x
∗
2(NR2 − x∗2 − 2x∗4 − x∗5) + 2β22−x4,
B55 = b12+x
∗
1(NR2 − x∗2 − 2x∗4 − x∗5) + b21+x∗2(NR1 − x∗1 − 2x∗3 − x∗5) + β12−x∗5 + β21−x∗5.
van Kampen approximation for Model 3.2 In the case of Model 3.2 the deterministic variables are given by
(M1,M2, D1, D2, DM , P2, PM ) ∼ (x1, x2, x3, x4, x5, x6, x7),
35
and the deterministic equations can be written as
dx1
dt
= 2a1+(NR1 − x1 − 2x3 − x5)(NL − x1 − x2 − x3 − x4 − x5)
− b11+x1(NR1 − x1 − 2x3 − x5)− b12+x1(NR2 − x2 − 2x4 − x5)
− α1−x1 + 2β11−x3 + β12−x5,
dx2
dt
= 2a2+(NR2 − x2 − 2x4 − x5)(NL − x1 − x2 − x3 − x4 − x5)
− b22+x2(NR2 − x2 − 2x4 − x5)− b21+x2(NR1 − x1 − 2x3 − x5)
− α2−x2 + 2β22−x4 + β21−x5,
dx3
dt
= −2β11−x3 + b11+x1(NR1 − x1 − 2x3 − x5),
dx4
dt
= b22+x2(NR2 − x2 − 2x4 − x5)− 2β22−x4 − γ22+x4 + γ22−x6,
dx5
dt
= b12+x1(NR2 − x2 − 2x4 − x5) + b21+x2(NR1 − x1 − 2x3 − x5)− β12−x5 − β21−x5
− γ12+x5 + γ12−x7,
dx6
dt
= γ22+x4 − γ22−x6,
dx7
dt
= γ12+x5 − γ12−x7.
For Model 3.2 (competition model with delayed phosphorylation), the coefficients Aij and Bij = Bji are the same
as in Model 3.1, except for the following
A44 = −2b22+x∗2 − 2β22− − γ22+,
A55 = −b12+x∗1 − b21+x∗2 − β12− − β21− − γ12+,
A46 = γ22−,
A64 = γ22+,
A66 = −γ22−,
A57 = γ12−,
A75 = γ12+,
A77 = −γ12−,
B44 = b22+x
∗
2(NR2 − x∗2 − 2x∗4 − x∗5) + 2β22−x4 + γ22−x∗6 + γ22+x∗4,
B55 = b12+x
∗
1(NR2 − x∗2 − 2x∗4 − x∗5) + b21+x∗2(NR1 − x∗1 − 2x∗3 − x∗5) + β12−x∗5 + β21−x∗5 + γ12−x∗7 + γ12+x∗5,
B46 = −2γ22−x∗6 − 2γ22+x∗4,
B57 = −2γ12−x∗7 − 2γ12+x∗5,
B66 = γ22−x∗6 + γ22+x
∗
4,
B77 = γ12−x∗7 + γ12+x
∗
5.
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